###begin article-title 0
Functions, structure, and read-through alternative splicing of feline APOBEC3 genes
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 91 103 <span type="species:ncbi:9685">domestic cat</span>
###xml 105 116 <span type="species:ncbi:9685">Felis catus</span>
APOBEC3 (A3, Apolipoprotein B mRNA-editing catalytic polypeptide 3) genes in the genome of domestic cat (Felis catus) were identified and characterized
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 80 85 <span type="species:ncbi:9606">human</span>
Over the past years a variety of host restriction genes have been identified in human and mammals that modulate retrovirus infectivity, replication, assembly, and/or cross-species transmission. Among these host-encoded restriction factors, the APOBEC3 (A3; apolipoprotein B mRNA-editing catalytic polypeptide 3) proteins are potent inhibitors of retroviruses and retrotransposons. While primates encode seven of these genes (A3A to A3H), rodents carry only a single A3 gene.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 85 96 85 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Felis catus</italic>
###xml 71 83 <span type="species:ncbi:9685">domestic cat</span>
###xml 85 96 <span type="species:ncbi:9685">Felis catus</span>
###xml 137 140 <span type="species:ncbi:9685">cat</span>
###xml 510 528 <span type="species:ncbi:53182">feline foamy virus</span>
###xml 664 693 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
###xml 698 719 <span type="species:ncbi:11768">feline leukemia virus</span>
Here we identified and characterized several A3 genes in the genome of domestic cat (Felis catus) by analyzing the genomic A3 locus. The cat genome presents one A3H gene and three very similar A3C genes (a-c), probably generated after two consecutive gene duplications. In addition to these four one-domain A3 proteins, a fifth A3, designated A3CH, is expressed by read-through alternative splicing. Specific feline A3 proteins selectively inactivated only defined genera of feline retroviruses: Bet-deficient feline foamy virus was mainly inactivated by feA3Ca, feA3Cb, and feA3Cc, while feA3H and feA3CH were only weakly active. The infectivity of Vif-deficient feline immunodeficiency virus and feline leukemia virus was reduced only by feA3H and feA3CH, but not by any of the feA3Cs. Within Felidae, A3C sequences show significant adaptive selection, but unexpectedly, the A3H sequences present more sites that are under purifying selection.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
Our data support a complex evolutionary history of expansion, divergence, selection and individual extinction of antiviral A3 genes that parallels the early evolution of Placentalia, becoming more intricate in taxa in which the arms race between host and retroviruses is harsher.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 18 29 18 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Felis catus</italic>
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 643 644 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 722 723 722 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 782 783 782 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 905 906 905 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1599 1600 1599 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 4 16 <span type="species:ncbi:9685">domestic cat</span>
###xml 18 29 <span type="species:ncbi:9685">Felis catus</span>
###xml 148 151 <span type="species:ncbi:9685">cat</span>
###xml 221 250 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
###xml 252 255 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 293 321 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 323 326 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 329 332 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 342 346 <span type="species:ncbi:9685">cats</span>
###xml 379 382 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 524 528 <span type="species:ncbi:9685">cats</span>
###xml 573 594 <span type="species:ncbi:11768">Feline leukemia virus</span>
###xml 596 600 <span type="species:ncbi:11768">FeLV</span>
###xml 637 641 <span type="species:ncbi:9685">cats</span>
###xml 654 672 <span type="species:ncbi:53182">feline foamy virus</span>
###xml 674 677 <span type="species:ncbi:53182">FFV</span>
###xml 776 780 <span type="species:ncbi:9685">cats</span>
###xml 786 789 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 856 860 <span type="species:ncbi:9689">lion</span>
###xml 862 869 <span type="species:ncbi:32536">cheetah</span>
###xml 875 879 <span type="species:ncbi:9696">puma</span>
###xml 891 903 <span type="species:ncbi:9685">domestic cat</span>
###xml 1437 1449 <span type="species:ncbi:9685">domestic cat</span>
###xml 1584 1589 <span type="species:ncbi:9606">human</span>
###xml 1594 1597 <span type="species:ncbi:9615">dog</span>
###xml 1761 1766 <span type="species:ncbi:9606">human</span>
###xml 1771 1781 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1793 1798 <span type="species:ncbi:10090">mouse</span>
###xml 1803 1806 <span type="species:ncbi:10116">rat</span>
###xml 1825 1828 <span type="species:ncbi:9685">cat</span>
###xml 1833 1836 <span type="species:ncbi:9615">dog</span>
The domestic cat (Felis catus) is an established animal model for studies of the brain, genetics, pharmacology, and nutrition [1]. In addition, the cat serves as a model for viral infectious diseases. For instance, since feline immunodeficiency virus (FIV) shares many features in common with human immunodeficiency virus (HIV), FIV-infected cats serve as an important model for HIV/AIDS, for example, with respect to therapy, vaccination and pathogenesis [2]. In addition, two other exogenous retroviruses are prevalent in cats, with very different outcomes of infection. Feline leukemia virus (FeLV) is a serious oncogenic pathogen of cats [3] whereas feline foamy virus (FFV) has not been firmly linked to any disease [4] and shows potential as a gene transfer vehicle for cats [5]. FIV is endemic to at least 21 free ranging Felidae species, including lion, cheetah, and puma as well as domestic cat [6], while the prevalence of other feline viruses is less characterized. Although molecular and genetic features of these feline retroviruses have been unraveled over the past years, studies on the contribution of host genes in permissiveness towards virus replication and especially in actively restricting virus multiplication, determining disease, and influencing spread and transmission are only now becoming possible due to new achievements in genomics. Recently, the lightly covered whole genome shotgun (WGS) sequences of the domestic cat (1.9x genome coverage) were assembled and annotated based on the comparison with conserved sequence blocks of the genome sequences of human and dog [7]. The detailed upcoming 7x WGS sequence and analysis of the feline genome will provide an important mammalian comparative genome sequence relative to primates (human and chimpanzee), rodents (mouse and rat), and carnivores (cat and dog) and will likely provide new insights into disease inheritance and the relationship between genetic background of the host and infectious diseases.
###end p 10
###begin p 11
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 939 941 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1109 1112 1109 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif</italic>
###xml 1224 1226 1224 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1227 1229 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 340 346 <span type="species:ncbi:9606">humans</span>
###xml 407 412 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 594 597 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 870 899 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 901 904 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 907 910 <span type="species:ncbi:53182">FFV</span>
###xml 912 915 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 920 937 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 1068 1073 <span type="species:ncbi:9606">human</span>
The APOBEC3 (A3; for apolipoprotein B mRNA-editing catalytic polypeptide 3) genes are of particular interest because they form part of the intrinsic immunity against retroviruses (for a review see [8]), are under a high adaptive selection [9], and might have undergone a relatively recent unique evolutionary expansion in primates [10]. In humans, A3F and A3G specifically are capable of terminally editing HIV-1 by deamination of cytidine to uracil during reverse transcription in addition to other, still ill-defined antiviral activities [11]. However, the virion infectivity factor (Vif) of HIV actively counteracts this host-mediated restriction [12-16]. The interaction between Vif and A3 proteins is species-specific and may thus limit cross-species virus transmission [17]. Similar editing has been implicated in the replication of a number of viruses, including simian immunodeficiency virus (SIV), FFV, FIV and hepatitis B virus [18-21]. While foamy retroviruses also utilize an accessory viral protein (Bet) to counteract A3 inactivation, other viruses like human T-cell leukemia virus have evolved vif-independent mechanisms to evade A3-mediated restriction, underpinning the importance of this host restriction [21-23].
###end p 11
###begin p 12
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 120 123 <span type="species:ncbi:9615">dog</span>
###xml 169 172 <span type="species:ncbi:9685">cat</span>
###xml 351 354 <span type="species:ncbi:9685">cat</span>
###xml 715 718 <span type="species:ncbi:9685">cat</span>
Our objective was to identify and characterize A3 genes in the feline genome and compare them to those in the human and dog genomes. Fosmid clones used for the 1.9x WGS cat genome project and the accompanying data were organized into a database that could be used for targeted sequencing of regions underrepresented in the 1.9x genome sequence of the cat. We have used this resource to characterize the feline A3 region and to infer its evolutionary history. Our results reveal that, within Felinae, the A3 locus underwent a unique triplication of the A3C gene, whereas the A3H gene exists as a single copy. In addition, we found a gene read-through generating a double-domain A3CH protein. APOBEC3 proteins of the cat are active inhibitors of various feline retroviruses and show differential target specificity.
###end p 12
###begin title 13
Results
###end title 13
###begin p 14
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 162 165 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bet</italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 289 293 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 356 360 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 546 555 542 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F. catus </italic>
###xml 797 799 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 87 99 <span type="species:ncbi:9685">domestic cat</span>
###xml 176 179 <span type="species:ncbi:53182">FFV</span>
###xml 189 192 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 293 296 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 372 375 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 500 503 <span type="species:ncbi:9685">cat</span>
###xml 546 554 <span type="species:ncbi:9685">F. catus</span>
###xml 611 614 <span type="species:ncbi:9685">cat</span>
Recently we described an antiviral cytidine deaminase of the A3 family in cells of the domestic cat [21]. Feline A3 (feA3) was found to be an active inhibitor of bet-deficient FFV [21] and SIV (data not shown and see below), but failed to show antiviral activity against wild-type or Deltavif FIV (data not shown and see below). However, the presence of a vif gene in the FIV genome, assumed to counteract the anti-viral activity of A3 proteins, strongly argues for additional feline APOBEC3s in the cat. This prompted us to search the genome of F. catus more thoroughly for A3 genes. Initial attempts to clone cat A3 cDNAs by a combination of PCR and 5' and 3' rapid amplification of cDNA ends (RACE) detected, in addition to feA3, at least two more A3-related RNAs in the feline cell line CrFK [24].
###end p 14
###begin title 15
Genomic organization of the feline APOBEC3 locus
###end title 15
###begin p 16
###xml 1238 1247 1238 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F. catus </italic>
###xml 1669 1670 1669 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 62 74 <span type="species:ncbi:9685">domestic cat</span>
###xml 255 260 <span type="species:ncbi:9606">human</span>
###xml 265 268 <span type="species:ncbi:9615">dog</span>
###xml 343 346 <span type="species:ncbi:9685">cat</span>
###xml 467 470 <span type="species:ncbi:9685">cat</span>
###xml 555 567 <span type="species:ncbi:9685">domestic cat</span>
###xml 1054 1059 <span type="species:ncbi:9606">human</span>
###xml 1061 1066 <span type="species:ncbi:10090">mouse</span>
###xml 1068 1071 <span type="species:ncbi:9615">dog</span>
###xml 1075 1080 <span type="species:ncbi:4932">yeast</span>
###xml 1238 1246 <span type="species:ncbi:9685">F. catus</span>
Comparative genomic analysis has shown that the genome of the domestic cat contains gene sequences orthologous to AICDA (activation-induced cytidine deaminase; also known as AID) and APOBEC1, 2, 3 and 4 in that they map to syntenic chromosomal regions of human and dog. The chromosomal localizations of APOBEC1, 2, 3 and 4, were determined on cat chromosomes B4, B2, B4, and F1, respectively. To further identify and characterize A3 genes in the annotated Abyssinian cat genome sequence, we studied fosmids that had been end-sequenced as part of the 1.9x domestic cat genome project from Agencourt Bioscience Corporation. To establish a web-based fosmid cloning system, the 1,806 fosmid 384-well plates were stored in assigned locations. A fosmid database of 1,288,606 fosmid clones, sequence-trace IDs, plate and well IDs, and freezer location IDs was generated and linked to the GARFIELD browser and the National Center for Biotechnology Information (NCBI) trace IDs. In this system, fosmid cloning is achieved by using potential orthologues (that is, human, mouse, dog or yeast) of genes of interest and searching for fosmid trace IDs by gene ID/symbol in the GARFIELD browser or by discontinuous MEGABLAST of orthologous sequences to F. catus WGS at the NCBI BLAST site. With the trace ID, the fosmid freezer location ID can be retrieved from the fosmid database. We have tested 704 fosmids and could identify with a 99% accuracy 616 of them (87.5%), as confirmed by fosmid end-sequencing. Using this system, we selected a total of seven fosmids that were predicted to encompass A3 genes and three clones were subsequently analyzed by nucleotide sequencing (Figure 1).
###end p 16
###begin p 17
###xml 48 52 48 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 654 658 654 658 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 735 739 735 739 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
Gene organization of the feline APOBEC3 region. (a) Shown is a Pipmaker analysis of the 50 kb nucleotide sequence of the APOBEC3 region showing the intron/exon organization of the four identified feline A3 genes (A3Cc, A3Ca, A3Cb and A3H) and annotation of repetitive elements (see inset for key: Simple, simple repeat sequence poly(dT-dG).poly(dC-dA); LTR, long terminal repeat retrotransposons; SINE, short interspersed elements; SINE/MIR, MIRs are tRNA-derived SINEs that amplified before the mammalian radiation; SINE/lys, tRNA-lys-derived SINE; LINE1, long interspersed element 1; LINE 2, long interspersed element-2; CpG/GpC ratios are indicated). (b) Organization and gene content of the fosmids used for nucleotide sequencing. (c) Self-dotplot of the percent identities of the A3C region showing the high degree of sequence identity between A3Cc, A3Ca, and A3Cb.
###end p 17
###begin p 18
###xml 7 9 7 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a,b</xref>
###xml 719 720 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 725 726 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1133 1137 1133 1137 <bold xmlns:xlink="http://www.w3.org/1999/xlink">AGG </bold>
###xml 1137 1138 1137 1138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 1137 1140 1137 1140 <underline xmlns:xlink="http://www.w3.org/1999/xlink"><bold>T</bold>GA</underline>
###xml 178 181 <span type="species:ncbi:9685">cat</span>
Figure 1a shows a percent identity alignment of the 50 kb A3 region sequenced aligned to itself. Gene modeling studies using the predicted nucleotide and amino acid sequences of cat A3 and A3H cDNAs and the programs Spidey [25] and Genewise [26] demonstrated the presence of three feline A3C genes designated A3Ca (identical to A3C cDNA [21]), A3Cb and A3Cc and a single A3H gene arrayed in a head-to-tail formation spanning 32 kb of the 50 kb region sequenced (Figure 1a,b). The A3C genes each consist of four exons with coding sequences that span 3,693, 6,457 and 6,498 bp for A3Cc, A3Ca, and A3Cb, respectively, whereas A3H contains one 5' untranslated exon followed by four coding exons that span 2,237 bp (Figures 1 and 2). Consensus splice acceptor sites were observed for exons 2 to 4 in the three A3C genes and exons 2 to 5 in the A3H gene. Consensus splice donor sites were observed for exons 1 to 4 in A3H and in all four coding exons of the three A3C genes. Interestingly, splicing at the splice donor sites of exon 4 (bold) in all A3C genes eliminates the overlapping termination codon (underlined) of the feA3 cDNA (CTT AGG TGA), allowing the generation of chimeric read-through transcripts. Consensus polyadenylation signals (AATAAA) were observed at positions downstream of exon 4 for all three A3C genes - A3Ca (positions 32,505, 33,376 and 33,444), A3Cb (positions 42,083, 42,954 and 43,022), and A3Cc (positions 22,960 and 23,831) - and A3H (position 50,319).
###end p 18
###begin p 19
Representation of the feline APOBEC3 genomic region, portraying the detected A3 transcripts. Transcripts with translated exon (rectangles) and spliced-out introns (dotted lines) are indicated. Please note that the transcript for A3H comes in two versions: with complete exon 2 and further spliced exon 2, resulting in 5' truncation (Ex. H2 5'Delta). The mRNA for A3CH includes exon 4 of A3Cb in an additionally spliced version, 3' truncating the sequence one nucleotide before the stop codon (Ex. Cb4 3'Delta).
###end p 19
###begin p 20
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 1674 1676 1674 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 400 405 <span type="species:ncbi:9606">human</span>
###xml 581 584 <span type="species:ncbi:9685">cat</span>
###xml 1493 1496 <span type="species:ncbi:9685">cat</span>
###xml 1547 1552 <span type="species:ncbi:9606">human</span>
###xml 1597 1600 <span type="species:ncbi:9615">dog</span>
###xml 1619 1622 <span type="species:ncbi:9615">dog</span>
###xml 1656 1661 <span type="species:ncbi:9606">human</span>
###xml 1733 1738 <span type="species:ncbi:9606">human</span>
###xml 1795 1798 <span type="species:ncbi:9685">cat</span>
###xml 1802 1805 <span type="species:ncbi:9615">dog</span>
The initially identified cDNA of feA3 (A3Ca) and the coding sequences of the genes A3Cb and A3Cc show 97.6% and 98.9% identical nucleotides, respectively, and 96.3-96.5% identical amino acids to each other. The predicted proteins of A3Cb and A3Cc differ in six or seven amino acids from feA3 (A3Ca; Figure 3; Figure S2 in Additional data file 3). The feline A3C genes show high overall similarity to human A3C with 43.3-43.8% identical amino acids (Figure S2 in Additional data file 3). In addition to the high degree of sequence identity between the coding sequences of the three cat A3C genes, the pattern of repetitive elements, especially in intron 1 of A3Ca and A3Cb (Figure 1A), and self dotplot analyses (Figure 1c) suggested significant sequence identity in noncoding regions of these highly related genes. Supplementary Table 1 in Additional data file 2 shows the size of each intron and the pairwise percent identities between the introns of the three genes: the introns of A3Ca and A3Cb have a high degree of nucleotide sequence identity (98-99%) across all three introns whereas A3Cc shows a lower degree of sequence identity to either A3Ca or A3Cb (67-96%), depending on the size of the intron. Based on the very high similarity of the A3C genes, two gene duplications in rather recent evolutionary times seem to be highly likely. The first duplication yielded A3Cc and an A3Ca/b progenitor gene. A3Ca/b subsequently duplicated again, resulting in A3Ca and A3Cb. As expected, the cat A3C genes have a more distant relationship to the human A3C group, the feline A3H clusters with the dog A3H gene, but the dog A3A is only distantly related to human A3A (Figure 4a). Double-domain APOBEC3 genes structurally analogous to human A3F or A3G have not been found in the genomes of either cat or dog.
###end p 20
###begin p 21
###xml 86 90 86 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 240 244 240 244 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 117 129 <span type="species:ncbi:9685">domestic cat</span>
###xml 608 620 <span type="species:ncbi:9685">domestic cat</span>
###xml 1358 1363 <span type="species:ncbi:9606">human</span>
Comparison of the nucleotide coding and amino acid sequences of the feline A3C genes. (a) Pairwise comparison of the domestic cat A3 cDNA to the predicted A3Ca, A3Cb and A3Cc genomic coding sequences and the predicted amino acid sequences. (b) Amino acid sequence alignment of A3C cDNA and the predicted proteins for A3C genes. Highlighted in yellow are amino acid residues different between the A3Cs based on the genomic sequence, whereas amino acid sites displaying non-synonymous amino acid substitutions are boxed in blue and red for A3Cb and A3Cc, respectively, as identified by SNP genotyping of eight domestic cat breeds for exons 2-4 of A3Ca, A3Cb and A3Cc (for more details see Table 4 in Additional data file 2). Arrows indicate exonic junctions. Below the alignments, variant amino acids are boxed in red for A3Cc (for example, W65R) and blue for A3Cb with respect to the breed from which they were identified: Turkish van (VAN), Egyptian mau (MAU), Sphynx (SPH), Birman (BIR) and Japanese bobtail (BOB). A dash indicates the amino acid is identical to genomic sequence. Numbers adjacent to breed identifiers refer to alleles 1 and 2 identified by clonal sequence analysis of the PCR products that are in phase for exons 3 and 4, but not for exon 2 (1/2). The residue corresponding to functionally significant amino acid replacement identified in human A3G (D128K) is highlighted by an asterisk (see text).
###end p 21
###begin p 22
###xml 55 59 55 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 850 856 850 856 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b,c) </bold>
Phylogenetic analyses of the feline A3C and A3H genes. (a) Maximum clade credibility tree obtained after Bayesian phylogenetic inference with BEAST for the three large clusters of APOBEC3 sequences: A3A, A3C and A3H. Domains in two-domain proteins were split and analyzed separately, their position in the original sequence indicated as CT or NT, for carboxy-terminal or amino-terminal, respectively. Values in the nodes indicate corresponding support, as follows: Bayesian posterior probability/maximum likelihood (percentage after 500 cycles bootstrap)/distance analysis (percentage after 1,000 cycle bootstrap) parsimony analysis (percentage after 1,000 cycles bootstrap). The scale bar is given in substitutions per site. The domains within the A3 proteins can be divided into three groups of related proteins: A3H (Z2), A3A (Z1B) and A3C (Z1A). (b,c) Zoom-in on the maximum clade credibility tree obtained after Bayesian phylogenetic inference with BEAST, focusing on the Felinae APOBEC3C sequences (b) and APOBEC3H (c) sequences. Values in the nodes indicate corresponding support, as in the main tree in (a). The scale bar is given in substitutions per site. Figures above the branches indicate Ka/Ks ratios, calculated using Diverge. In some instances, zero synonymous substitutions lead to an apparent Ka/Ks ratio of infinity.
###end p 22
###begin title 23
Expression of feline APOBEC3 genes
###end title 23
###begin p 24
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 2060 2062 2060 2062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 2359 2361 2359 2361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 2613 2614 2613 2614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1223 1227 <span type="species:ncbi:9685">cats</span>
###xml 1752 1756 <span type="species:ncbi:9685">cats</span>
###xml 1867 1879 <span type="species:ncbi:9685">domestic cat</span>
Initially, we applied 3' RACE assays using the A3Ca sequence in order to clone additional feline A3 cDNAs. We detected the single-domain A3H and a cDNA composed of the fused open reading frames of A3C and A3H, designated A3CH [24]. A closer inspection of the sequence of A3CH revealed that the transcript is encoded by exons 1-3 of A3Ca, the complete coding sequence of exon 4 of A3Cb and exons 2-5 of A3H (Figure 2). Importantly, the consensus splice donor of exon 4 of A3Cb, located only one nucleotide 5' of the stop codon TGA, is used for in-frame splicing to A3H exons 2-5. The double-domain A3CH RNA was found in three tested cell lines (CrFK, MYA-1, KE-R) and also in feline peripheral blood mononuclear cells (PBMCs; Figure 5a). In 20 cloned PCR products from independent reverse-transcriptase (RT)-PCR reactions using RNA from CrFK, MYA-1 and PBMCs, the A3CH cDNAs were always exactly as described above (exons 1-3 of A3Ca, the 3' truncated exon 4 of A3Cb and exons 2-5 of A3H). In no case did we observe sequence variation in the A3CH mRNA, for example, by contribution of other A3C exons. We used diagnostic PCR primers to analyze the expression of A3Ca, A3Cb, A3Cc, and A3H in total RNA of feline PBMCs (of two cats of unknown pedigree) and cell lines (CrFK, KE-R, MYA-1). About half of the mRNAs from the activated feline PBMCs corresponded to A3Ca (22 of 40 clones) and approximately 17% were identical with A3Cb (7 of 40 clones) as determined by RT-PCR allowing detection of all three A3Cs. The remaining PCR products of A3C cDNAs represented additional variants, designated A3Cx and A3Cy, each containing six amino acid differences relative to A3Ca (Figure S1 in Additional data file 3), indicating further genetic allelic variation in cats. Sequence-based genotyping by direct PCR of genomic DNA using locus specific primers for exons 2-4 from eight domestic cat breeds resulted in finding zero, thirteen, and four non-synonymous substitutions and zero, one, and two synonymous substitutions in A3Ca, A3Cb and A3Cc genes, respectively (Figure 3b; details in supplementary Table 4 in Additional data file 2). MYA-1 cells expressed A3Ca, A3Cb and A3Cc genes (15, 5 and 1 clone out of 21, respectively), but CrFK and KE-R cells expressed only A3Ca (10 of 10 clones for each). Feline A3H was detected in all analyzed cell lines and PBMCs (Figure 5a). Interestingly, the transcript for A3H seems to be subject to alternative splicing, since we consistently detected an additional variant containing a 5' truncated exon 2, generating a cDNA with a 149 nucleotide shorter 5' untranslated region (Figure 2).
###end p 24
###begin p 25
###xml 49 55 49 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a,b) </bold>
###xml 278 279 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 360 364 360 364 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 228 232 <span type="species:ncbi:9689">lion</span>
###xml 234 238 <span type="species:ncbi:9696">puma</span>
###xml 248 253 <span type="species:ncbi:9694">tiger</span>
###xml 255 260 <span type="species:ncbi:9694">tiger</span>
###xml 390 393 <span type="species:ncbi:9685">cat</span>
###xml 419 425 <span type="species:ncbi:9986">rabbit</span>
###xml 488 491 <span type="species:ncbi:9685">cat</span>
Expression analysis of feline A3C, A3H and A3CH. (a,b) Analysis of expression of feline A3C, A3H and A3CH by RT-PCR of total RNA from feline cell lines (CrFK, MYA-1, KE-R) and feline PBMCs (a) and expression of A3CH in PBMCs of lion, puma, Sumatra-tiger (tiger), and lynx (b). H2O indicates PCRs using primers specific for the A3s without template cDNA added. (c) Analysis of expression of cat A3CH by immunoblot using rabbit serum against the sequence flanked by the C- and H-domains in cat A3C (linker) using 293T cells transfected with A3 expression plasmid or empty vector as indicated and CrFK and MyA-1 cells (two independent cultures each).
###end p 25
###begin p 26
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c</xref>
###xml 152 155 <span type="species:ncbi:9685">cat</span>
In order to determine whether the different A3 proteins are present in feline CrFK and MYA-1 cells, immunoblot analyses using antisera directed against cat A3C and A3H as well as a serum directed against the A3CH-specific sequence flanked by the C- and H-domains in A3CH (linker) were employed. In extracts from CrFK and MYA-1 cells the anti-linker serum detected a protein band that clearly co-migrated with A3CH expressed from plasmid pcfeA3CH in transfected 293T cells (Figure 5c). The C- and H-domain-specific antisera detected the corresponding A3C and A3H proteins in CrFK cells while only after over-exposition of the immunoblot was the A3CH protein detectable with these sera (data not shown). This detection pattern may reflect low-level expression of A3CH or may indicate that the corresponding epitopes are masked in the two-domain A3CH protein.
###end p 26
###begin p 27
###xml 755 757 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1263 1265 1263 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 2110 2112 2110 2112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 90 102 <span type="species:ncbi:9685">domestic cat</span>
###xml 1050 1053 <span type="species:ncbi:9860">Elk</span>
###xml 1246 1251 <span type="species:ncbi:9606">human</span>
###xml 2099 2104 <span type="species:ncbi:9606">human</span>
To search for transcription factor binding sites that might regulate A3 expression in the domestic cat A3 gene cluster, we first aligned the upstream 1.1 kb, including 100 bp of the predicted exon 1 for each gene A3Ca, A3Cb, A3Cc, and A3H using ClustalW. This analysis showed considerable sequence similarity in the proximal 5' flanking sequences of all four A3 genes, with A3Cc the most divergent (Figure S3 in Additional data file 3). Using MEME to search for conserved sequence elements in a set of DNA sequences using an expectation-maximization algorithm, we detected two highly conserved 50 bp sequence motifs between all four promoter regions, one located flanking the putative transcription start site and the other approximately 200 bp upstream [27,28]. Individual 5' flanking sequences were analyzed using the Match program, which uses a library of nucleotide weight matrices from the TRANSFAC6.0 database for transcription factor binding sites [29]. The first 50 bp motif contains putative transcription factor binding sites for HNF-4 and Elk-1 as well as a site reportedly present in all phenobarbital-inducible promoters 30 bp upstream of the transcriptional start site. No obvious TATA or CAAT boxes were identified, similar to the human A3 region [30]. The second site (200 bp upstream of the start site) includes Octamer and Evi-1 transcription factor binding sites, which are associated with transcription in hematopoietic cell lineages. Further 5', the sequences and predicted transcription factor binding sites of A3Ca, A3Cb and A3H are relatively well conserved whereas A3Cc is divergent, suggesting that A3Cc has a unique transcription profile as indicated in our RT-PCR expression studies. Another approach to identify transcription factor binding sites, ModelInspector uses a library of experimentally verified promoter modules or models that consist of paired transcription factor binding sites, orientation, order and distance. Using this method, we identified four paired transcription factor binding sites shared between one or more of the feline A3 promoters and that of human A3G [31], including two ETS-SP1 (A3Ca, A3Cb, A3Cc and A3H), IKRS-AP2 (A3H), and NFkappaB paired with either CEBP (A3Ca and A3Cb), RBPF (A3Ca, A3Cb and A3Cc) or STAT (A3Ca, A3Cb and A3H). Future studies are required to demonstrate the potency of these elements.
###end p 27
###begin title 28
Diversity of APOBEC3 in the family Felidae
###end title 28
###begin p 29
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 451 476 451 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panthera leo bleyenberghi</italic>
###xml 501 526 501 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panthera tigris sumatrae </italic>
###xml 530 554 530 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panthera tigris corbetti</italic>
###xml 566 592 566 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panthera pardus japonensis</italic>
###xml 601 610 601 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lynx lynx</italic>
###xml 622 635 622 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Puma concolor</italic>
###xml 652 660 652 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F. catus</italic>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 935 939 935 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b,c</xref>
###xml 1831 1833 1831 1833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 445 449 <span type="species:ncbi:9689">lion</span>
###xml 451 476 <span type="species:ncbi:472295">Panthera leo bleyenberghi</span>
###xml 483 488 <span type="species:ncbi:9694">tiger</span>
###xml 501 525 <span type="species:ncbi:9695">Panthera tigris sumatrae</span>
###xml 530 554 <span type="species:ncbi:74534">Panthera tigris corbetti</span>
###xml 557 564 <span type="species:ncbi:9691">leopard</span>
###xml 566 592 <span type="species:ncbi:348288">Panthera pardus japonensis</span>
###xml 601 610 <span type="species:ncbi:13125">Lynx lynx</span>
###xml 616 620 <span type="species:ncbi:9696">puma</span>
###xml 622 635 <span type="species:ncbi:9696">Puma concolor</span>
###xml 652 660 <span type="species:ncbi:9685">F. catus</span>
###xml 893 905 <span type="species:ncbi:9685">domestic cat</span>
###xml 1010 1014 <span type="species:ncbi:9689">lion</span>
###xml 1019 1024 <span type="species:ncbi:9694">tiger</span>
###xml 1190 1195 <span type="species:ncbi:9694">tiger</span>
###xml 1215 1220 <span type="species:ncbi:9694">tiger</span>
###xml 1318 1323 <span type="species:ncbi:9694">tiger</span>
###xml 1394 1399 <span type="species:ncbi:9694">tiger</span>
###xml 1414 1419 <span type="species:ncbi:9694">tiger</span>
###xml 1539 1544 <span type="species:ncbi:9694">tiger</span>
###xml 1673 1678 <span type="species:ncbi:9694">tiger</span>
###xml 1761 1765 <span type="species:ncbi:9689">lion</span>
###xml 1767 1771 <span type="species:ncbi:9696">puma</span>
###xml 1781 1786 <span type="species:ncbi:9694">tiger</span>
###xml 1797 1804 <span type="species:ncbi:9691">leopard</span>
It was demonstrated that primate A3 genes are under a strong positive selection predating modern lentiviruses [9,32,33]. Currently, it is not known whether the rapid adaptive selection of A3 genes is unique to primates or represents rather a general feature of Placentalia. To gain further insight into this question, we analyzed A3 sequences of additional Felidae species. We cloned the orthologous cDNAs of A3C and A3H from activated PBMCs of lion (Panthera leo bleyenberghi), two tiger subspecies (Panthera tigris sumatrae and Panthera tigris corbetti), leopard (Panthera pardus japonensis), lynx (Lynx lynx) and puma (Puma concolor). Together with F. catus, this collection comprises four of the eight extant lineages within Felidae [34]. We characterized two to six transcripts for A3C and A3H of each species, one animal per species. The phylogenetic relationships and identities to the domestic cat A3 genes are shown in Figure 4b,c, and supplementary Tables 5 and 6 in Additional data file 2. In lynx, lion and tiger, the cDNAs for A3C depicted some degree of intra-species genetic variability and all variants were included in our analysis. In three of six A3C isolates of Sumatra-tiger and both Indochina-tiger cDNAs, the sequence encoded a lysine at position 185, while in the three other clones of Sumatra-tiger a glutamate was encoded. No further diversity in A3C-cDNAs of Sumatra-tiger and Indochina-tiger was found. We detected only a single type of A3H transcript in each of the above-mentioned felid species. In Indochina-tiger A3H, we found a polymorphism encoding either an arginine or a lysine at amino acid position 65, whereas in A3H cDNAs of Sumatra-tiger, only K65 was seen. The A3CH transcript was also detected in cDNA preparations of lion, puma, Sumatra-tiger and lynx (leopard was not analyzed) (Figure 5b).
###end p 29
###begin p 30
###xml 926 928 926 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1247 1251 1247 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b,c</xref>
###xml 1409 1411 1409 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1412 1414 1412 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1667 1669 1667 1669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 2062 2064 2042 2044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 2213 2215 2189 2191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 2216 2218 2192 2194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 707 712 <span type="species:ncbi:9606">human</span>
###xml 849 852 <span type="species:ncbi:9685">cat</span>
###xml 854 859 <span type="species:ncbi:9694">tiger</span>
###xml 861 865 <span type="species:ncbi:9689">lion</span>
###xml 870 877 <span type="species:ncbi:9691">leopard</span>
###xml 981 985 <span type="species:ncbi:9696">puma</span>
###xml 2224 2227 <span type="species:ncbi:9685">cat</span>
###xml 2237 2240 <span type="species:ncbi:9685">cat</span>
###xml 2303 2306 <span type="species:ncbi:9685">cat</span>
Comparing non-synonymous substitution rates (Ka) and synonymous substitution rates (Ks) within the alignment of the A3C and A3H cDNA sequences, several Ka/Ks ratios were above 1, indicating positive selection among the A3C sequences (Table 2 in Additional data file 2) and the A3H sequences (Table 3 in Additional data file 2) of the different felids. Because extreme Ka/Ks ratios below or above 1 may appear when only few residues are under positive or purifying selection, we used the sliding window approach to determine whether defined regions of the A3 proteins are under any type of selection. The results in Figure S4 in Additional data file 3 show that comparison of feline A3s to the corresponding human A3s do not show clear positive or negative selection as expected due to the evolutionary divergence. In contrast, positive selection of cat, tiger, lion and leopard A3Cs peaks around 200 bp (at the start of the Zn2+-coordinating domain) while comparison with lynx and puma A3Cs reveal different sites under positive selection. In the case of A3H the sliding window comparison was not meaningful because the small number of substitutions led to many infinity values due to Ks = 0. Therefore, the trees of the A3C and A3H genes (Figure 4b,c) were further tested for the presence of selection among amino acid sites using the Phylogenetic Analysis by Maximum Likelihood (PAML) program version 3.15 [35,36]. Evaluating the difference of the maximum likelihood values for the trees calculated with different evolutionary models, a probability estimate for positive selection can be deduced. In the case of A3H the difference is not statistically significant (P = 0.4; Additional data files 1 and 2), but in model 2, which allows for three different omega values (omega = 1 means neutral evolution, omega < 1 purifying selection, omega > 1 positive selection), 71% of A3H are summarized with omega = 0, supporting purifying selection as the simplest evolutionary model. In contrast, positive selection can be found for several residues for A3C sequences (P < 0.0001; 15% of A3C are summarized with omega = 7.2 under model 2). Comparable results were obtained when using the webserver Selecton version 2.2 [37,38] for cat A3Ca and cat A3Cc with the alignment of A3C with all felid species and for cat A3H using the alignment of A3H sequences (data not shown).
###end p 30
###begin title 31
The diverse feline APOBEC3s differentially inhibit feline retroviruses
###end title 31
###begin p 32
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bet</italic>
###xml 94 97 90 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bet</italic>
###xml 100 102 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 562 564 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 33 36 <span type="species:ncbi:9685">cat</span>
###xml 81 84 <span type="species:ncbi:53182">FFV</span>
###xml 200 203 <span type="species:ncbi:9615">dog</span>
###xml 248 251 <span type="species:ncbi:53182">FFV</span>
###xml 253 256 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 261 265 <span type="species:ncbi:11768">FeLV</span>
###xml 425 428 <span type="species:ncbi:9685">cat</span>
###xml 504 507 <span type="species:ncbi:9685">cat</span>
###xml 512 517 <span type="species:ncbi:9606">human</span>
In a recent study we showed that cat A3Ca is a potent inhibitor of bet-deficient FFV (FFVDeltabet) [21]. We were interested to extend this finding and tested A3Ca, A3Cb, A3Cc, A3H and A3CH as well as dog A3A and A3H with viral reporter systems for FFV, FIV and FeLV. To monitor the activity of the A3s, plasmids expressing hemagglutinin (HA)-tagged versions of A3 were used. All A3 proteins could be detected in immunoblots; cat A3Ca, A3Cb, A3Cc and A3CH were comparably expressed, and the expression of cat and human A3H was reduced three- to five-fold (Figure 6a).
###end p 32
###begin p 33
###xml 79 83 79 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 192 198 192 198 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b-e) </bold>
###xml 221 225 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bet </italic>
###xml 323 327 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 396 400 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 0 3 <span type="species:ncbi:9685">Cat</span>
###xml 225 228 <span type="species:ncbi:53182">FFV</span>
###xml 254 257 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 272 275 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 327 330 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 373 377 <span type="species:ncbi:11768">FeLV</span>
Cat A3 proteins selectively inhibit the infectivity of different retroviruses. (a) A3 expression in the transfected 293T cells was detected by immunoblotting with anti-HA monoclonal antibody. (b-e) Wild-type (wt) or Deltabet FFV wild type (b), wild-type FIV-Luc, Deltavif FIV-Luc + Vif expression plasmid (vif.V5) and Deltavif FIV luciferase reporter vector particles (c), FeLV/GFP (d), and Deltavif SIVagm luciferase viruses (e) were produced in 293T cells in the presence or absence of the indicated APOBEC3s.
###end p 33
###begin p 34
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 514 518 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bet </italic>
###xml 748 752 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bet </italic>
###xml 928 932 916 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 949 953 933 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 1205 1207 1189 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6c</xref>
###xml 1281 1284 1261 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif</italic>
###xml 1522 1526 1498 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 1605 1609 1577 1581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 1695 1699 1663 1667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bet </italic>
###xml 1798 1800 1766 1768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1827 1831 1791 1795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 2105 2109 2061 2065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 62 65 <span type="species:ncbi:53182">FFV</span>
###xml 149 152 <span type="species:ncbi:53182">FFV</span>
###xml 291 294 <span type="species:ncbi:53182">FFV</span>
###xml 376 379 <span type="species:ncbi:53182">FFV</span>
###xml 480 483 <span type="species:ncbi:53182">FFV</span>
###xml 518 521 <span type="species:ncbi:53182">FFV</span>
###xml 664 667 <span type="species:ncbi:53182">FFV</span>
###xml 692 695 <span type="species:ncbi:9615">Dog</span>
###xml 752 755 <span type="species:ncbi:53182">FFV</span>
###xml 769 772 <span type="species:ncbi:53182">FFV</span>
###xml 814 817 <span type="species:ncbi:9685">cat</span>
###xml 825 828 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 830 856 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 897 900 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 913 916 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 932 935 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 953 956 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1239 1242 <span type="species:ncbi:9685">cat</span>
###xml 1405 1410 <span type="species:ncbi:9606">human</span>
###xml 1446 1449 <span type="species:ncbi:9615">dog</span>
###xml 1526 1529 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1544 1547 <span type="species:ncbi:9615">dog</span>
###xml 1609 1612 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1699 1702 <span type="species:ncbi:53182">FFV</span>
###xml 1707 1712 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1831 1834 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 2109 2112 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 2998 3001 <span type="species:ncbi:11673?1.0">FIV</span>
The effect of A3 co-expression on wild-type and Bet-deficient FFV was studied after transfection of 293T cells. For this purpose, the infectivity of FFV titers was determined two days after transfection by using FeFAB reporter cells [39]. Cotransfection of A3Ca did not reduce the wild-type FFV titer, whereas a 700-fold reduction in titer was detected with the Bet-deficient FFV (Figure 6b), as described previously [21]. Quite similarly, A3Cb and A3Cc did not inhibit wild-type FFV but reduced the titer of Deltabet FFV by 200- and 70-fold, respectively. Feline A3H and A3CH showed a comparable low antiviral activity and reduced Bet-deficient but not wild-type FFV to a much lower degree. Dog A3A and A3H did not inhibit the infectivity of Deltabet FFV or wild-type FFV. To assess the antiviral activity of the cat A3s on FIV, vesicular stomatitis virus-G protein (VSV-G) pseudotyped wild-type FIV-luciferase (FIV-Luc), Deltavif FIV-Luc and Deltavif FIV-Luc cotransfected with Vif expression plasmid (pcFIV.Vif-V5) reporter vectors were generated in 293T cells in the presence of A3 expression plasmids. Equal amounts of particles were used for transduction experiments. The results depicted in Figure 6c show that only two of the five cat A3 proteins are inhibitors of FIVDeltavif-mediated gene transfer: feline A3H and A3CH reduced the infectivity by five- and ten-fold, respectively, similar to the human A3H. Feline A3Ca, A3Cb or A3Cc and dog A3A expression plasmids did not reduce infectivity of wild-type or Deltavif FIV. In contrast, dog A3H showed antiviral activity against wild-type and Deltavif FIV, causing a three-fold reduction. We recently showed that the inactivation of Deltabet FFV and HIV-1 by feline A3s was attributable to cytidine deamination of viral reverse transcripts [21]. The suppression of Deltavif FIV by feline A3H and A3CH also correlates with a significant increased G-->A mutation rate in the viral genomes (Figure S5a,b in Additional data file 3): cotransfection of feA3H or feA3CH resulted in 1.61% and 1.31% G-->A substitutions, respectively. Viral genomes of Deltavif FIV derived from transfections omitting an A3 expression plasmid showed no G-->A editing; using feA3Ca, feA3Cb or feA3Cc expression plasmids, only 0.1% G-->A exchanges were detectable at most. These data highly correlate with the inhibitory activity detected in the infectivity studies. The presence of Vif protein inhibited the genome editing nearly completely (Figure S5 in Additional data file 3). The sequence context of the majority of the G-->A exchanges in the viral genomes derived from co-expressing feA3H and feA3CH showed no clear preference for a dinucleotide: feA3H induced 17% GG-->AG, 35% GA-->AA and 42% GC-->AC exchanges in the positive strand of the DNA. The editing context of the A3CH showed 28% GG-->AG changes, 39% GA-->AG mutations, and 28% GC-->AC changes. Both A3s edited in 5-6% GT-->AT dinucleotides (Figure S5c in Additional data file 3). Interestingly, in the FIV system, the more antiviral A3CH generated slightly lower numbers of mutations than the less antiviral A3H (Figure S5a,b,d in Additional data file 3). This result could point either to additional and unknown activities of A3 proteins or to differences between the degradation kinetics of uracil-containing DNAs.
###end p 34
###begin p 35
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6d</xref>
###xml 790 794 786 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 935 937 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6e</xref>
###xml 25 28 <span type="species:ncbi:9685">cat</span>
###xml 63 67 <span type="species:ncbi:11768">FeLV</span>
###xml 98 102 <span type="species:ncbi:11768">FeLV</span>
###xml 120 124 <span type="species:ncbi:11768">FeLV</span>
###xml 192 196 <span type="species:ncbi:11768">FeLV</span>
###xml 220 241 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 243 246 <span type="species:ncbi:11786">MLV</span>
###xml 378 382 <span type="species:ncbi:11768">FeLV</span>
###xml 534 537 <span type="species:ncbi:9685">cat</span>
###xml 547 550 <span type="species:ncbi:9615">dog</span>
###xml 589 593 <span type="species:ncbi:11768">FeLV</span>
###xml 611 614 <span type="species:ncbi:9685">Cat</span>
###xml 623 626 <span type="species:ncbi:9615">dog</span>
###xml 693 697 <span type="species:ncbi:11768">FeLV</span>
###xml 813 816 <span type="species:ncbi:9685">cat</span>
###xml 839 842 <span type="species:ncbi:9615">dog</span>
###xml 881 884 <span type="species:ncbi:9615">Dog</span>
###xml 923 926 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
To analyze the impact of cat A3 proteins on the infectivity of FeLV, we used a molecular clone of FeLV subgroup A (p61E-FeLV). Reporter particles were generated by co-transfection of the p61E-FeLV packaging construct, a murine leukemia virus (MLV)-based green fluorescent protein (GFP)-reporter genome, a VSV-G pseudotyping plasmid and the different A3 expression plasmids. The FeLV/GFP virions were normalized for RT activity and used for infection of 293T cells. The GFP expression pattern of the inoculated cells demonstrated that cat A3Cs and dog A3H did not reduce the infectivity of FeLV/GFP (Figure 6d). Cat A3H and dog A3A had a marginal effect and A3CH showed a significant effect on FeLV, inhibiting the virus by a factor of 5. We also tested the simian lentivirus SIVagm-LucDeltavif and found that all cat A3s, except A3Cc, and dog A3H showed strong antiviral activity. Dog A3A did not reduce the infectivity of SIV (Figure 6e).
###end p 35
###begin p 36
###xml 103 107 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bet </italic>
###xml 142 146 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bet </italic>
###xml 248 252 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 509 511 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 252 255 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 301 305 <span type="species:ncbi:11768">FeLV</span>
###xml 326 329 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 415 420 <span type="species:ncbi:9606">human</span>
###xml 441 444 <span type="species:ncbi:53182">FFV</span>
In summary, the feline A3Ca, A3Cb, and A3Cc proteins displayed very high activity only against FFVDeltabet while A3H and A3CH reduced FFVDeltabet infectivity much less. In contrast, only feline A3H and A3CH had a moderate inhibitory effect on Deltavif FIV, and A3CH weakly but significantly inhibited FeLV. The Vif protein of FIV counteracted feline A3H and A3CH, but failed to neutralize the antiviral activity of human and canine A3H. The FFV Bet protein mainly counteracted feline A3Ca, as recently shown [21], and A3Cb and A3Cc. We conclude that the various feline A3 proteins differentially target feline retroviruses with a remarkable virus-specific profile.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 1063 1065 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 29 41 <span type="species:ncbi:9685">domestic cat</span>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 77 80 <span type="species:ncbi:9615">dog</span>
###xml 99 102 <span type="species:ncbi:9685">cat</span>
###xml 107 110 <span type="species:ncbi:9615">dog</span>
###xml 140 145 <span type="species:ncbi:9606">human</span>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 416 421 <span type="species:ncbi:9606">human</span>
###xml 470 475 <span type="species:ncbi:9606">human</span>
###xml 525 530 <span type="species:ncbi:9606">human</span>
###xml 596 601 <span type="species:ncbi:9606">human</span>
###xml 642 647 <span type="species:ncbi:9606">human</span>
###xml 665 670 <span type="species:ncbi:9606">human</span>
###xml 726 731 <span type="species:ncbi:9606">human</span>
###xml 857 869 <span type="species:ncbi:9685">domestic cat</span>
###xml 999 1004 <span type="species:ncbi:9606">human</span>
###xml 1034 1037 <span type="species:ncbi:9685">cat</span>
###xml 1080 1092 <span type="species:ncbi:9685">domestic cat</span>
###xml 1171 1174 <span type="species:ncbi:9685">cat</span>
###xml 1206 1209 <span type="species:ncbi:9615">dog</span>
###xml 1254 1257 <span type="species:ncbi:9685">cat</span>
###xml 1326 1329 <span type="species:ncbi:9685">cat</span>
###xml 1382 1385 <span type="species:ncbi:9685">cat</span>
###xml 1730 1733 <span type="species:ncbi:9685">cat</span>
Phylogenetic analysis of the domestic cat APOBEC genes relative to human and dog demonstrated that cat and dog contain genes orthologous to human AICDA (AID), APOBEC1 (A1), A2, A3 and A4. The human A3 gene cluster on chromosome 22 spans 130 kb and contains seven genes that can be classified according to the presence/absence of the Z1a, Z1b and Z2 zinc-coordinating motifs [32,40]. Z1a, the A3C family, consists of human A3C, the carboxy- and amino-terminal domains of human A3DE and A3DF, and the amino-terminal domains of human A3B and A3G (Figure 4a). The Z1b group, the A3A family, contains human A3A and the carboxy-terminal domains of human A3B and A3G. The human A3H represents the Z2 zinc-finger domain. Accordingly, human A3B, A3G, A3DE, and A3F have two domains, while A3A, A3C, and A3H have one domain. Our analysis shows that the genome of the domestic cat contains three A3C genes (A3Ca to A3Cc) in addition to one A3H. The feline A3C genes have a single domain and are related to the human Z1a group but form their own cat specific lineage (Figure 4a). None of the domestic cat genes identified fall into the Z1b group. Cross-species BLAST analyses of the cat 1.9x genome sequence employing dog predicted genes for A3A and A3H using NCBIs cat WGS contig, trace and end-sequence databases failed to identify any cat gene other than A3C and A3H. Presumably, either the cat does not contain Z1b family genes or these genes are not represented in the 1.9x sequence. The fosmid DNA library and database described here provide an additional genomic DNA resource for isolation and characterization of feline genes involved in infectious and inherited disease. Since the fosmids in the library have been mapped to the 1.9x cat genomic sequence by end sequencing, it is not necessary to screen genomic libraries by hybridization or PCR to isolate genes of interest as with previous genomic libraries.
###end p 38
###begin p 39
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif</italic>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 626 627 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 877 878 877 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1051 1053 1051 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 55 60 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 141 146 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 181 186 <span type="species:ncbi:9606">human</span>
###xml 257 262 <span type="species:ncbi:9606">human</span>
###xml 479 482 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 508 513 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 539 543 <span type="species:ncbi:11768">FeLV</span>
###xml 571 574 <span type="species:ncbi:53182">FFV</span>
###xml 576 579 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 664 667 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 691 695 <span type="species:ncbi:4456">apes</span>
###xml 725 728 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 766 769 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 816 819 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 885 889 <span type="species:ncbi:11768">FeLV</span>
###xml 957 960 <span type="species:ncbi:53182">FFV</span>
###xml 987 990 <span type="species:ncbi:53182">FFV</span>
###xml 1030 1041 <span type="species:ncbi:37029">leopard cat</span>
Human A3G and A3F have been shown to be active against HIV-1, which lacks the virion infectivity factor (vif) [13-16,41]. The Vif protein of HIV-1 exclusively binds and inactivates human A3 proteins in a species-specific way [17]. The D128K mutation in the human A3G gene altered the Vif interaction [42-44] and H186R correlated with slow AIDS progression in African American populations [45]. In felids three types of exogenous retroviruses are known: within Orthoretroviridae, FIV, a lentivirus related to HIV-1, and the gammaretrovirus FeLV; and, within Spumavirinae, FFV. FIV infects both wild and domestic felid species [6]. Similar to the diversification of SIV in African monkeys and apes, species-specific strains of FIV have been described [46]. But unlike SIV, which is detectable only in African species, FIV is endemic in African, South American and Asian Felidae [6]. For FeLV the prevalence in wild species is not known and limited studies on FFV supported the presence of FFV-related isolates in two species of the leopard cat lineage [47].
###end p 39
###begin p 40
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 667 671 663 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 678 680 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 681 683 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 133 136 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 165 170 <span type="species:ncbi:9606">human</span>
###xml 221 224 <span type="species:ncbi:9685">cat</span>
###xml 282 285 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 306 309 <span type="species:ncbi:9685">cat</span>
###xml 417 429 <span type="species:ncbi:9685">domestic cat</span>
###xml 563 569 <span type="species:ncbi:9606">humans</span>
###xml 574 578 <span type="species:ncbi:9685">cats</span>
###xml 604 609 <span type="species:ncbi:9606">human</span>
###xml 671 676 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The ability of Vif proteins to counteract the antiviral activity of A3 proteins is specific for a virus-host system. Thus, while the HIV-Vif protein counteracts the human A3F and A3G proteins, it is not effective against cat A3H and A3CH, as we recently reported [24]. In contrast, FIV-Vif neutralizes the cat A3H and A3CH induced cytidine deamination. Since we could not detect homologous genes to A3F or A3G in the domestic cat genome, the essential role of controlling retrovirus replication seems to be covered by different A3 proteins in permissive mammals (humans and cats). Interestingly, neither human A3C nor A3H proteins are inhibitors of wild-type or Deltavif HIV-1 [18,32], supporting a host-specific genetic adaptation of A3 genes.
###end p 40
###begin p 41
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 288 299 288 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. concolor</italic>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 770 775 770 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Puma </italic>
###xml 812 818 812 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Felis </italic>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1037 1046 1037 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F. catus </italic>
###xml 1252 1256 1248 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 1342 1346 1334 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bet </italic>
###xml 1571 1575 1559 1563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 16 19 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 80 83 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 224 237 <span type="species:ncbi:9685">domestic cats</span>
###xml 288 299 <span type="species:ncbi:9696">P. concolor</span>
###xml 334 338 <span type="species:ncbi:9685">cats</span>
###xml 386 389 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 510 514 <span type="species:ncbi:9685">cats</span>
###xml 770 774 <span type="species:ncbi:9696">Puma</span>
###xml 902 905 <span type="species:ncbi:9685">cat</span>
###xml 974 977 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1023 1026 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1037 1045 <span type="species:ncbi:9685">F. catus</span>
###xml 1164 1167 <span type="species:ncbi:9685">Cat</span>
###xml 1226 1230 <span type="species:ncbi:11768">FeLV</span>
###xml 1256 1259 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1346 1349 <span type="species:ncbi:53182">FFV</span>
The vif gene of FIV is a relevant modulator of spreading virus infection, since FIV in which the vif gene was deleted showed a replication block in feline CrFK cells that express A3, as we showed [21,24,48]. Furthermore, in domestic cats experimentally infected with FIVpco isolated from P. concolor, the virus was controlled and the cats did not develop clinical signs associated with FIV infection. The restriction of FIVpco was attributed to feline A3 proteins, because the viral genomes of FIVpco grown in cats accumulated extensive G-to-A mutations [20]. It is likely that insufficient molecular recognition and inactivation of heterologous feline A3 by the Vif protein of FIVpco caused this attenuated virus infection. It is interesting to emphasize here that the Puma genus is the closest relative of the Felis genus, having diverged approximately 6.7 million years ago [34]. The ability of the cat A3 proteins to limit FIVpco infection while not being able to limit FIV infection may thus reflect the fact that the FIV infecting F. catus has evolved the potential to escape A3-mediated restriction of its host since the divergence of both felide lineages. Cat A3H and A3CH also showed some inhibitory activity against FeLV. In contrast to Deltavif FIV, these active antiviral proteins showed only weak antiviral activity against Deltabet FFV. Based on these findings, we conclude that specific feline A3 proteins selectively recognize and inactivate only defined subgroups of feline retroviruses, while 'non-adapted', heterologous retroviruses (for example, Deltavif SIVagm) can be inactivated by all three types of feA3s with the remarkable exception of feA3Cc. These data also reflect the fact that even without expression of Vif or Bet proteins, retroviruses differ, for unknown reasons, in their vulnerability to cognate A3 proteins.
###end p 41
###begin p 42
###xml 1406 1418 1406 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. concolor </italic>
###xml 1544 1549 1544 1549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Puma </italic>
###xml 1553 1559 1553 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Felis </italic>
###xml 1635 1645 1635 1645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. tigris </italic>
###xml 1766 1775 1766 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panthera </italic>
###xml 1783 1789 1783 1789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Felis </italic>
###xml 2093 2095 2093 2095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 2096 2098 2096 2098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 55 58 <span type="species:ncbi:9685">cat</span>
###xml 457 470 <span type="species:ncbi:9685">domestic cats</span>
###xml 763 766 <span type="species:ncbi:9685">cat</span>
###xml 888 900 <span type="species:ncbi:9685">domestic cat</span>
###xml 1406 1417 <span type="species:ncbi:9696">P. concolor</span>
###xml 1441 1444 <span type="species:ncbi:9685">cat</span>
###xml 1544 1548 <span type="species:ncbi:9696">Puma</span>
###xml 1635 1644 <span type="species:ncbi:9694">P. tigris</span>
###xml 1668 1671 <span type="species:ncbi:9685">cat</span>
###xml 2178 2182 <span type="species:ncbi:9685">cats</span>
###xml 2381 2385 <span type="species:ncbi:9615">dogs</span>
The analysis of the genomic sequences and cDNAs of the cat A3 loci allowed us to identify three key-features not present in the primate A3 system: first, one ancestral A3C gene underwent two successive duplication events in recent times - the first event generated the ancestor of the present A3Cc gene and a second gene, which later on underwent a second duplication giving rise to the ancestors of the present A3Ca and A3Cb genes; second, the A3H gene in domestic cats is under purifying selection; and third, the double-domain A3CH is generated by a read-through transcription and alternative splicing of three genes. In addition, we detected at least 15 single nucleotide polymorphisms (SNPs) yielding non-synonymous substitutions in A3C genes of 8 different cat breeds. In primates, the seven A3 genes (A3A to A3H) are present as single copies on chromosome 22. In the genome of the domestic cat, we found three copies of the A3C gene (A3Ca, A3Cb and A3Cc) in a head-to-tail orientation on chromosome B4. The feline A3C genes encode proteins that are different to each other at six to seven amino acid sites. Phylogenetic analyses indicate that this gene triplication likely occurred by two consecutive duplication steps: one ancestral A3C gene duplicated to the ancestor of A3Cc and a second gene, which later duplicated, giving rise to A3Ca and A3Cb genes. The presence of a homologous A3Cc gene in P. concolor closely related to the cat A3Cc gene suggests that at least the first duplication event occurred before the divergence of the Puma and Felis lineages, approximately 6.7 million years ago. The phylogenetic position of P. tigris A3C basal to the three cat A3C genes suggests also that the first duplication event occurred after the divergence of the Panthera and the Felis lineages, approximately 10.8 million years ago. It is generally believed that the evolution of new protein functions after gene duplication plays an important role in the evolution of the diversity of organisms and typically allows for an increased specialization or function gain of the daughter genes [49,50]. In light of the seven A3 genes in primates, it is tempting to speculate that cats, like primates, were under a specific evolutionary pressure to increase the diversity of the co-expressed A3 proteins that provided additional fitness. Other mammals, such as rodents and eventually dogs, were either not faced by these infectious agents or managed to counteract retroviruses and related retroid elements in a way not involving A3 proteins.
###end p 42
###begin p 43
###xml 67 68 67 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 309 312 <span type="species:ncbi:53182">FFV</span>
###xml 327 330 <span type="species:ncbi:9685">cat</span>
###xml 431 434 <span type="species:ncbi:9685">cat</span>
###xml 446 449 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 454 458 <span type="species:ncbi:11768">FeLV</span>
###xml 523 526 <span type="species:ncbi:53182">FFV</span>
###xml 706 709 <span type="species:ncbi:9685">cat</span>
###xml 849 852 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 857 861 <span type="species:ncbi:11768">FeLV</span>
###xml 941 944 <span type="species:ncbi:9685">cat</span>
###xml 1292 1295 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1300 1304 <span type="species:ncbi:11768">FeLV</span>
###xml 1378 1381 <span type="species:ncbi:9685">cat</span>
###xml 1418 1421 <span type="species:ncbi:9685">cat</span>
While primate A3 genes are under an adaptive (positive) selection [9,32,33], we detected significant positive selection only for the feline A3C genes. Feline A3H was found to have more residues under purifying selection than feline A3C. It thus appears that restriction against an apparently innocuous virus (FFV), mediated in cat by the A3C genes, is under high selective pressure whereas A3H, which is active against two serious cat pathogens, FIV and FeLV, does not evolve adaptively. While we consider it unlikely that FFV has a strong but currently unidentified pathogenic potential, it is possible that restriction against additional pathogens has shaped this evolutionary pattern. For instance, the cat A3H may protect against highly conserved, endogenous retroelements or may act by targeting highly conserved, invariant viral structures of FIV and FeLV, both features that would result in purifying selection. It could also be that cat A3H took over additional important functions distinct from pathogen defense, inducing purifying selection. Finally, the combination of a conserved A3H domain carrying specifically optimized effecter functions with a highly adaptive module allowing recognition of changing targets may explain that the two-domain feA3CH is much more active against FIV and FeLV than the corresponding single-domain molecules that are either inactive (cat A3C) or have intermediate activity (cat A3H). We postulate that the generation of the fused A3CH transcript is an evolutionary way to gain a greater variety of proteins from a limited number of functional exons.
###end p 43
###begin p 44
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 822 825 822 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 847 852 847 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 76 79 <span type="species:ncbi:9685">cat</span>
###xml 398 403 <span type="species:ncbi:9606">human</span>
###xml 440 445 <span type="species:ncbi:9606">human</span>
###xml 941 944 <span type="species:ncbi:9685">cat</span>
###xml 1020 1023 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1028 1032 <span type="species:ncbi:11768">FeLV</span>
###xml 1063 1066 <span type="species:ncbi:9685">cat</span>
###xml 1124 1127 <span type="species:ncbi:9685">cat</span>
In order to express the potent anti-retroviral restriction factor A3CH, the cat has modularly combined sequences from A3Ca and A3Cb genes and the constant A3H domain. This was likely achieved by read-through transcription. Read-through transcription, also called transcription-induced chimerism, a mechanism where adjacent genes produce a single, fused RNA transcript, is found in at least 2-5% of human genes [51,52]. A general feature of human transcriptional read-through is that intergenic sequences in these RNAs are processed via the standard eukaryotic splicing machinery that removes introns from RNA transcripts. Intergenic splicing is favored in closely located gene pairs [51,52], as true for the triplicated feline A3C genes. Currently, the regulation of read-through transcription is uncharacterized and both cis-acting sequences and trans-acting suppressors/regulators of the termination machinery could regulate it. Since the cat A3CH protein displayed a significantly stronger antiviral activity against FIV and FeLV compared to the single-domain cat A3C and A3H proteins, the read-through transcription for cat A3 appears to be functionally relevant.
###end p 44
###begin p 45
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1060 1065 1060 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1232 1234 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1235 1237 1235 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 584 590 <span type="species:ncbi:9606">humans</span>
###xml 857 869 <span type="species:ncbi:9685">domestic cat</span>
###xml 925 928 <span type="species:ncbi:9685">cat</span>
In this study we did not investigate whether the upstream genes (A3Ca and A3Cb) have legitimate transcription termination sites, and whether the downstream gene (A3H) has a legitimate promoter region. But consensus sequences for both regulatory elements are detectable using standard analysis tools (Figure S3 in Additional data file 3). This analysis showed considerable sequence similarity in the proximal 5' flanking sequences of all A3 genes except A3Cc, which has a unique upstream sequence, supporting the experimental data that A3Cc may have a unique transcription profile. In humans, A3 genes are differentially expressed in tissues associated with either endogenous or exogenous retroviral replication, including testes, the ovary and un-stimulated and stimulated peripheral blood lymphocytes (for a review, see [53]). Analysis of cDNA clones from domestic cat PBMCs, and MYA-1, CrFK and KE-R cells suggest that the cat A3 genes are also differentially expressed. An alternative possibility, however, is that the fused transcript of A3CH results from trans-splicing between separate pre-mRNAs of A3Ca, A3Cb and A3H genes. The amount of trans-splicing in mammals is unknown and only few examples have been described so far [54,55].
###end p 45
###begin p 46
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 504 506 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 507 509 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 631 633 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 710 712 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 783 788 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 791 793 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1103 1105 1099 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1809 1810 1805 1806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 7 12 <span type="species:ncbi:9606">human</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10116">rats</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 874 877 <span type="species:ncbi:9913">cow</span>
###xml 879 882 <span type="species:ncbi:9823">pig</span>
###xml 884 889 <span type="species:ncbi:9940">sheep</span>
###xml 1020 1025 <span type="species:ncbi:9606">human</span>
###xml 1092 1097 <span type="species:ncbi:9606">human</span>
###xml 1250 1253 <span type="species:ncbi:9615">dog</span>
In the human A3 locus there is evidence of gene expansion. It was speculated that duplications of single-domain genes formed the two-domain A3B or A3G, and, subsequently, duplication of A3B or A3G formed A3F [30]. Primates and rodents are both part of the placentalia super-order of Euarchontoglires (synonymous with Supraprimates). While primates have seven A3 genes (A3A to A3H), mice and rats carry only a single A3 gene. In mice, in addition, a splice variant lacking exon 5 (A3Delta5) is expressed [17,56]. Based on these data, it was proposed that primates show a relatively recent and possibly unprecedented gene expansion [10] or that the gene expansion happened at the beginning of primate evolution [40]. The lack of data from other mammals was partially filled by Jonsson et al. [57], who characterized A3 proteins, designated A3Fs, from certain cetartiodactyla (cow, pig, sheep). Rodent and cetartiodactyla A3 proteins consist of two cytosine deaminase domains, where the amino-terminal domain is similar to human A3C and the carboxy-terminal domain shows the highest identity to human A3H [32]. This CH domain configuration is also found in feline A3CH described here. In our study we detected A3C and A3H genes in Felidae, while in the dog genome only genes corresponding to A3A and A3H are present. Cetartiodactyla and Carnivora are both grouped into the placentalia super-order of Laurasiatheria. Based on the presence of at least three different A3 types in Laurasiatheria, we propose that a certain set of A3 genes (A3A, A3C, A3H, or more) was already established before the separation of the placentalia order. During following evolution, this set of A3 genes was either preserved, fused, deleted or re-expanded depending on the specific requirements of the host-virus interactions (Figure 7). Following this idea, an initial expansion of a single A3 gene happened early in mammalian evolution, eventually before the appearance of the placentalia. Further studies on the absence or presence of A3 genes in the other placentalia super-orders (Xenathra and Afrotheria) and genomics in monotremata and marsupialia are necessary to critically evaluate our model of a two-stage evolution of A3 genes.
###end p 46
###begin p 47
###xml 993 998 989 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
Model of mammalian A3 gene evolution. The model proposes the presence of several A3 genes in Placentalia before the separation of the super-orders Afrotheria, Xenarthra, Euarchontoglires and Laurasiatheria. According to the phylogenetic relationships among the extant A3 proteins, a host-specific evolution of the A3 genes during the early evolution of the Placentalia orders by means of preservation, deletion and/or gene duplication and concomitant subfunctionalization or neofunctionalization is inferred. Successive duplication events from a single ancestral A3 gene might have generated multiple A3 genes before basal radiation within Placentalia. The divergence times of taxons is in millions of years (Myr) ago. Basal radiation within Monotremata and Marsupialia is not shown. A3, APOBEC3; A3Delta5, A3 lacking exon 5 derived amino acids. Relationship of taxa and timing of mammalian evolution is based on [85], but please note that the timing is controversial [86]. The study of Wible et al. [87] supports a later diversification of the placentalia superorders following the Cretaceous-Tertiary (K/T) boundary 65 million years ago.
###end p 47
###begin title 48
Conclusion
###end title 48
###begin p 49
###xml 169 177 169 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F. catus</italic>
###xml 155 167 <span type="species:ncbi:9685">domestic cat</span>
###xml 169 177 <span type="species:ncbi:9685">F. catus</span>
###xml 260 264 <span type="species:ncbi:9615">dogs</span>
###xml 352 355 <span type="species:ncbi:9685">cat</span>
Recent studies on the evolution of the primate APOBEC3 genes revealed a primate-specific gene amplification. We analyzed the genomic APOBEC3 region of the domestic cat (F. catus) and found a chromosomal APOBEC3 locus different to that of primates, rodents and dogs. Besides our detection of three very similar APOBEC3C genes and one APOBEC3H gene, the cat uses the mechanism of transcriptional read-through alternative splicing to generate a fifth antiviral APOBEC3 protein. The evolution of antiviral cytidine deaminases shows a strong placentalia family specific pattern. Our results indicate that three APOBEC3 genes (A, C and H) were present in the evolution of mammals before the placentalia super-orders separated.
###end p 49
###begin title 50
Materials and methods
###end title 50
###begin title 51
Fosmid database construction and utilization
###end title 51
###begin p 52
###xml 117 129 <span type="species:ncbi:9685">domestic cat</span>
A fosmid (pCC1) DNA library consisting of 693,504 clones containing an average insert size of approximately 40 kb of domestic cat (breed Abyssinian) genomic DNA arrayed in 1,806 384-well plates frozen at -80degreesC that was end-sequenced as part of the Feline Genome Project was obtained from Agencourt Bioscience, Inc. (Beverly, MA, USA) The bar-coded plates were recorded into a relational database using Filemaker Pro (Filemaker Inc., Santa Clara, CA, USA) according to their rack number and rack position in a -80degreesC freezer along with individual trace identification number, trace name, and clone identification number (which includes the location of each individual fosmid within the plate).
###end p 52
###begin title 53
Fosmid DNA isolation, PCR, and nucleotide sequencing
###end title 53
###begin p 54
###xml 281 282 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 486 487 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1040 1042 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 1189 1191 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 1192 1194 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 1260 1262 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1306 1308 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 1321 1323 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1337 1339 1297 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 1394 1396 1354 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 1598 1600 1549 1551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 1612 1614 1563 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 1615 1617 1566 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 1629 1631 1580 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1632 1634 1583 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
The appropriate well of a 384-well plate was picked using a culture loop and streaked across LB agar plates containing 12.5 mug/ml chloramphenicol and incubated at 37degreesC overnight. Fosmid DNA was isolated using a standard alkaline lysis procedure. DNA was diluted 1/1,000 in H2O and assayed by PCR containing 1.0 muM of primer pairs for feline sequence tagged sites, 200 muM deoxynucleoside 5'-triphosphates (dATP, dTTP, dCTP, dGTP), 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, and 1 unit TAQ-Gold polymerase in a 20 mul reaction at 95degreesC for 4 minutes followed by 30 cycles of 95degreesC for 30 s, 60degreesC for 30 s and 72degreesC for 30 s and 72degreesC for 7 minutes at the end of cycles. PCR products were analyzed on 2% agarose gels containing 0.5x Tris-Borate-EDTA buffer (TBE) and positive PCR products were treated with exonuclease/shrimp alkaline phosphatase and sequenced using BigDye Terminator chemistry with the appropriate forward and reverse primer and analyzed using an ABI 3730XL as described previously [58]. Fosmids were further analyzed by end sequencing and/or transposon insertions. Sequences were assembled using Phred, Phrap, and Consed programs [59-61]. Genomic nucleotide sequences were analyzed using RepeatMasker [62] to identify repetitive elements. Genscan [63], Genewise [26] and Spidey [64] were used to identify coding sequences and Pipmaker [65] to visualize sequence features. Potential regulatory sites, including transcription factor binding sites, splice donor/acceptor sites and polyadenylation sites, were identified using Matchtrade mark [66], WebLogo [67,68] and MEME [27,28].
###end p 54
###begin title 55
###xml 29 32 <span type="species:ncbi:9685">cat</span>
SNP analysis of A3C genes in cat breeds
###end title 55
###begin p 56
###xml 563 575 <span type="species:ncbi:9685">domestic cat</span>
The following locus specific PCR primers were used for PCR reactions: A3Ca_exon2_F (GCTGTTCTTTGGGGATAGAGAG); A3Cb_exon2_F (GGTTGGGGGTAGGGCGGGCT); A3Cc_exon2_F (CACCCACCAGGGACAACTCG); A3Ca_exon2_R (TGGTTCTCTCCTGGAAACAGA); A3Cb_exon2_R (AGGCTGTGGCTGGGAGCAGA); A3Cc_exon2_R (TCTGAGAGATCAGAGGGCCG); A3Ca_exon3_4_F (CTCAAAAAAAAAGACAGGGCAGA); A3Cb_exon3_4_F (TCAAAAAAAAAGACAGGGCAGG); A3Cc_exon3_4_F (GATGGATGGATGGATAGATGGAT); A3Ca_exon3_4_R (GCTGGGGAGGGAGGTGCGGA); A3Cb_exon3_4_R (GCTGGGGAGGGAGGTGCGGT); and A3Cc_exon3_4_R (GCTGGGGAGGGAGGTGCGGC). DNA samples for eight domestic cat breeds (Abysinnian, Birman, British Shorthair, Egyptian Mau, Japanese Bobtail, Norwegian Forest, Sphynx, and Turkish van) were amplified by PCR as described above except that we used 25 ng of DNA sample and the annealing temperature was increased to 64-70degreesC depending on primer pair and DNA sample. PCR products were analyzed as described above and assembled using Sequencher 4.7 (Genecodes, Ann Arbor, MI, USA).
###end p 56
###begin title 57
Phylogenetic analysis
###end title 57
###begin p 58
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 1164 1166 1164 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 1208 1210 1208 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 1814 1816 1814 1816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 2222 2224 2222 2224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 2225 2227 2225 2227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 57 60 <span type="species:ncbi:9615">dog</span>
###xml 142 145 <span type="species:ncbi:9615">dog</span>
###xml 180 192 <span type="species:ncbi:9685">Domestic cat</span>
###xml 228 233 <span type="species:ncbi:9606">human</span>
Reference sequences for human APOBEC genes and predicted dog APOBEC genes were identified from Ensembl, Refseq and the NCBI annotation of the dog 7x genome sequence, respectively. Domestic cat APOBEC genes were identified using human APOBEC reference gene sequences and were used to screen for traces containing related sequences. Genscan predicted genes were edited and aligned using Seqed and Clustalx (ABCC, NCI-Frederick, Frederick, MD, USA). The sequences used in the phylogenetic trees were aligned using Clustalw [69]. Manual correction of gaps and trimming of the homologous cDNA regions were accomplished with Jalview [70]. For consensus tree construction with bootstrap values, Seqboot (1,000 samples bootstrapping), Dnadist (maximum likelihood distance), Neighbor (UPGMA, jumble 10, different seed values), and Consense from the PHYLIP package [71] were run. The lengths of the branches were calculated with PAML3.15 (59; Model 0, Nssites 2, molecular clock, RateAncestor 1). The ancestral sequences for the different nodes were taken from the PAML result. Alternatively, cDNA sequences were translated and aligned at the amino acid level using MUSCLE [72], manually edited, filtered with GBLOCS [73], and then back-translated conserving the codon structure. Since some APOBEC proteins present two concatenated domains whereas others consist of a single domain, two-domain proteins were split and the individual domains analyzed separately. Parsimony analysis was performed with PROTPARS and with DNAPARS, from the PHYLIP package, after 1,000 cycles bootstrap. Distance analysis was performed using PROTDIST and Dnadist using both neighbor-joining and UPGMA (unweighted pair group method with arithmetic mean), and combining the results. Bayesian phylogenetic inference was performed with BEAST v1.4.6 [74], partitioning the nucleotide sequence following the three codon positions, under the Hasegawa-Kishino-Yano model of evolution, using a strict clock and a Jeffreys prior distribution for the coalescent population size parameter, with no phylogenetic constraints, in two independent chains of 10,000,000 generations, sampling every 1,000 generations. Maximum likelihood analysis were performed with RAxML [75,76] under the Wheland and Goldman model of evolution, executing 500 non-parametric bootstaps.
###end p 58
###begin title 59
Ka/Ks analysis of sequence pairs
###end title 59
###begin p 60
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 1018 1020 1008 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1473 1475 1459 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 313 316 <span type="species:ncbi:9685">cat</span>
###xml 1511 1514 <span type="species:ncbi:9685">cat</span>
Ka/Ks values between sequence pairs out of the alignments were calculated using the Diverge program (Wisconsin Package, Accelrys Inc (San Diego, CA, USA). For the sliding window approach (window 300 bp, slide 50 bp) the program was run with the appropriate part of the sequences. Test for positive selection: the cat A3C and A3H trees were further tested for the presence of positive selection among amino acid sites using PAML. The likelihood ratio test was used to compare the evolutionary models M1 (neutral) and M2 (selection), M7 (beta) and M8 (beta&omega variations) [77,78]. The likelihood ratio test statistic was calculated by 2 x logDelta, where Delta = L0 (null modeldata)/L1 (alternative modeldata), L0 is the likelihood estimate for the simple model, and L1 is the likelihood estimate for the model with more free parameters. The degrees of freedom were determined by the difference in the number of free parameters between the null and alternative models, and the test statistic was approximated to a chi2 distribution to determine statistical significance. In models M2 and M8, an empirical Bayesian approach is used to calculate the posterior probability that an amino acid site fits in each site class and sites with a high posterior probability of falling into the class of omega of >1 are considered to be under positive selection. Additionally, we identified the residues under positive and purifying selection using the webserver Selecton version 2.2 [37], submitting the alignments of the cat A3C and A3H sequences.
###end p 60
###begin title 61
Cells and transfections
###end title 61
###begin p 62
###xml 1229 1232 1228 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5 </sup>
###xml 1350 1351 1343 1344 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1371 1387 1364 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Canis familiaris</italic>
###xml 1465 1474 1458 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F. catus </italic>
###xml 1617 1636 1610 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. leo bleyenberghi</italic>
###xml 1647 1666 1640 1659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. tigris sumatrae </italic>
###xml 1670 1688 1663 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. tigris corbetti</italic>
###xml 1700 1720 1693 1713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. pardus japonensis</italic>
###xml 1729 1736 1722 1729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L. lynx</italic>
###xml 1748 1759 1741 1752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. concolor</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 374 380 <span type="species:ncbi:9913">bovine</span>
###xml 693 698 <span type="species:ncbi:9606">human</span>
###xml 969 972 <span type="species:ncbi:9615">dog</span>
###xml 1288 1293 <span type="species:ncbi:9606">human</span>
###xml 1366 1369 <span type="species:ncbi:9615">dog</span>
###xml 1371 1387 <span type="species:ncbi:9615">Canis familiaris</span>
###xml 1465 1473 <span type="species:ncbi:9685">F. catus</span>
###xml 1496 1500 <span type="species:ncbi:9685">cats</span>
###xml 1611 1615 <span type="species:ncbi:9689">lion</span>
###xml 1617 1636 <span type="species:ncbi:472295">P. leo bleyenberghi</span>
###xml 1639 1645 <span type="species:ncbi:9694">tigers</span>
###xml 1647 1665 <span type="species:ncbi:9695">P. tigris sumatrae</span>
###xml 1670 1688 <span type="species:ncbi:74534">P. tigris corbetti</span>
###xml 1691 1698 <span type="species:ncbi:9691">leopard</span>
###xml 1700 1720 <span type="species:ncbi:348288">P. pardus japonensis</span>
###xml 1729 1736 <span type="species:ncbi:13125">L. lynx</span>
###xml 1742 1746 <span type="species:ncbi:9696">puma</span>
###xml 1748 1759 <span type="species:ncbi:9696">P. concolor</span>
Human cell line 293T, and feline cell lines CrFK (ATCC CCL-94, feline kidney cells) and KE-R (feline embryonic fibroblast cells, a gift of Roland Riebe, Friedrich-Loeffler Institut, Riems) were maintained in Dulbecco's high glucose modified Eagle's medium (Biochrom, Berlin, Germany; Dulbecco's modified Eagle's medium complete) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 0.29 mg/ml L-glutamine, and 100 units/ml penicillin/streptomycin. Feline T-cell lines MYA-1 (ATCC CRL-2417) and FeT-1C (ATCC CRL-11968) were cultured in complete RPMI 1640, 0.29 mg/ml L-glutamine, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 0.05 mM 2-mercaptoethanol, 100 units/ml human recombinant interleukin-2 and 10% heat-inactivated FBS, and 100 units/ml penicillin/streptomycin. Plasmid transfection into 293T cells was done with Lipofectamine 2000 according to the manufacturer's instructions (Invitrogen, Karlsruhe, Germany). PBMCs of Felidae and a dog were isolated from EDTA- or heparin-treated whole blood by Histopaque-1077 (Sigma, Taufkirchen, Germany) gradient centrifugation and cultured after activation with phytohemagglutinin (PHA; 3 mug/ml) for 3 days in RPMI medium 1640 containing 15% FBS, 5 x 10-5 M 2-mercaptoethanol, 2 mM L-glutamine, and 100 units of human recombinant interleukin-2 per ml at 37degreesC and 5% CO2. Blood of one dog (Canis familiaris) of the breed Australian shepherd was obtained from Karin Kliemann. Blood of F. catus was obtained from two cats of unknown breed from the Max Planck Institute for Brain Research, Frankfurt, Germany. Blood from one each of lion (P. leo bleyenberghi), tigers (P. tigris sumatrae and P. tigris corbetti), leopard (P. pardus japonensis), lynx (L. lynx) and puma (P. concolor) were obtained from the Halle Zoo, Germany.
###end p 62
###begin title 63
Viruses and infections
###end title 63
###begin p 64
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 189 192 189 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif</italic>
###xml 264 266 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 289 292 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif</italic>
###xml 337 339 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 554 556 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 917 920 913 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Age</italic>
###xml 926 929 922 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa</italic>
###xml 1003 1005 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1049 1055 1045 1051 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ACCGGT</underline>
###xml 1081 1084 1077 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Age</italic>
###xml 1220 1226 1216 1222 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGGCCC</underline>
###xml 1244 1247 1240 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa</italic>
###xml 1440 1442 1436 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 1490 1492 1482 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 1771 1773 1763 1765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 2240 2242 2232 2234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 2401 2403 2393 2395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 0 3 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 37 40 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 121 124 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 230 233 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 591 594 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 715 740 <span type="species:ncbi:35269">Woodchuck hepatitis virus</span>
###xml 791 794 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1345 1349 <span type="species:ncbi:11768">FeLV</span>
###xml 1416 1420 <span type="species:ncbi:11768">FeLV</span>
###xml 1434 1438 <span type="species:ncbi:11768">FeLV</span>
###xml 1445 1448 <span type="species:ncbi:11786">MLV</span>
###xml 2211 2214 <span type="species:ncbi:53182">FFV</span>
###xml 2320 2323 <span type="species:ncbi:53182">FFV</span>
###xml 2354 2357 <span type="species:ncbi:53182">FFV</span>
FIV single-cycle luciferase vectors (FIV-Luc) were produced by cotransfecting 293T cells with: pFP93 (derived from clone FIV-34TF10, a gift of Eric M Poeschla [79]), which does not express vif; or pCPRDeltaEnv (derived from clone FIV-PPR, a gift of Garry P Nolan [80]), which does express vif; pLinSin; a VSV-G expression plasmid pMD.G [81]; and indicated APOBEC3-HA expression plasmids or empty vector (pcDNA3.1(+) (Invitrogen) or pcDNA3.1(+)zeo (Invitrogen). Vector pLiNSin was derived from pGiNSin, a self-inactivating (Sin) vector variant of pGiNWF [79], which is a minimal bi-cistronic FIV transfer vector plasmid coding for enhanced-green-fluorescent-protein (EGFP) and neomycin phosphotransferase containing Woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) and FIV central DNA flap. The EGFP gene in pGiNSin was replaced by the firefly luciferase gene (luc3) using the restriction sites AgeI and ApaI. The luciferase gene was amplified by overlapping PCR using pSIVagmLuc [17] as template and primers (feLuc3_1.f 5'-TCCACCGGTCGCCACCATGGAAGACGCCAA-3' (AgeI-restriction site underlined); feLuc3_1.r 5'-CGTTGGCCGCTTTACACGGCGATC-3'; feLuc3_2.f 5'-GATCGCCGTGTAAAGCGGCCAACG-3'; feLuc3_2.r 5'-TTCCGGGCCCTCACATTGCCAAA-3' (ApaI-restriction site underlined)), subcloned in pCR4Blunt-TOPO (Invitrogen), and sequence verified. FeLV reporter virions were produced by transfection of 293T cells with FeLV-A clone p61E-FeLV [82], MLV-EGFP transfer vector pMgEGFP-DeltaLNGFR [83], VSV-G expression plasmid and the indicated expression plasmid for APOBEC3-HA or pcDNA3.1(+). Reverse-transcription of viruses was determined by Cavidi HS kit Lenti RT or C-type RT (Cavidi Tech, Uppsala, Sweden). For reporter virus infections, HOS cells were seeded at 2.0 x 103 cells/well a day before transduction in 96-well plates and then infected with reporter virus stocks normalized for RT. Firefly luciferase activity was measured three days later with a Steadylite HTS reporter gene assay system (PerkinElmer, Cologne, Germany) according to the manufacturer's directions on a Berthold MicroLumat Plus luminometer. Expression of EGFP was analyzed by flow cytometry. Propagation of wild-type and Bet-deficient FFV (pCF-7 and pCF-Bet-BBtr [21]), contransfection with defined APOBEC3-HA expression plasmids, titration of FFV infectivity, and detection of FFV proteins was done as described previously [21].
###end p 64
###begin title 65
Sequencing of viral reverse transcripts
###end title 65
###begin p 66
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 101 105 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 397 402 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">egfp </italic>
###xml 427 431 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
###xml 105 108 <span type="species:ncbi:11673?1.0">FIV</span>
293T cells (1 x 106) were infected with DNase I (Roche, Mannheim, Germany) treated wild-type or Deltavif FIV(VSV-G) (1,000 pg RT) using vector pGiNSin produced in 293T cells together with feline APOBEC3s or pcDNA3.1(+). At 10 h post-infection, cells were washed with phosphate-buffered saline and DNA was isolated using DNeasy DNA isolation kit (Qiagen, Hilden, Germany). A 300 bp fragment of the egfp gene was amplified using Taq DNA polymerase and the primers eGFP.fw (5'-cgtccaggagcgcaccatcttctt-3') and eGFP.rv (5'-atcgcgcttctcgttggggtcttt-3'). Each of 30 cycles was run at 94degrees for 30 s, 58degrees for 1 minute, and 72degrees for 2 minutes, and PCR products were cloned into TOPO TA-cloning pCR4 vector (Invitrogen) and sequenced. The nucleotide sequences of at least eight independent clones were analyzed.
###end p 66
###begin title 67
Plasmids
###end title 67
###begin p 68
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 511 515 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pwo </italic>
###xml 617 623 616 622 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AAGCTT</underline>
###xml 711 717 710 716 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CTCGAG</underline>
###xml 776 779 775 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 842 848 841 847 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGTACC</underline>
###xml 873 876 872 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 929 935 928 934 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CTCGAG</underline>
###xml 992 995 991 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 1184 1187 1165 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 1196 1199 1177 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 1214 1217 1195 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 1223 1226 1204 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 1294 1307 1275 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. familiaris</italic>
###xml 1593 1597 1574 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pwo </italic>
###xml 1660 1666 1641 1647 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGTACC</underline>
###xml 1692 1695 1673 1676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 1761 1769 1742 1750 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GCGGCCGC</underline>
###xml 1825 1828 1806 1809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1972 1978 1952 1958 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGTACC</underline>
###xml 2008 2011 1988 1991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 2068 2076 2048 2056 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GCGGCCGC</underline>
###xml 2132 2135 2112 2115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 2160 2164 2140 2144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pwo </italic>
###xml 2316 2319 2278 2281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 2325 2328 2287 2290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 2673 2680 2635 2642 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GAATTCC</underline>
###xml 2740 2746 2702 2708 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GTCGAC</underline>
###xml 2811 2814 2773 2776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 2821 2824 2783 2786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 2998 3000 2960 2962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 3140 3144 3102 3106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 3235 3239 3197 3201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 3334 3337 3296 3299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 3343 3346 3305 3308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 3405 3408 3367 3370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 3414 3417 3376 3379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa</italic>
###xml 431 435 <span type="species:ncbi:9685">cats</span>
###xml 1289 1292 <span type="species:ncbi:9615">dog</span>
###xml 1294 1307 <span type="species:ncbi:9615">C. familiaris</span>
###xml 1415 1418 <span type="species:ncbi:9615">dog</span>
###xml 1641 1644 <span type="species:ncbi:9615">dog</span>
###xml 1743 1746 <span type="species:ncbi:9615">Dog</span>
###xml 1849 1852 <span type="species:ncbi:9615">Dog</span>
###xml 1954 1957 <span type="species:ncbi:9615">Dog</span>
###xml 2051 2054 <span type="species:ncbi:9615">Dog</span>
###xml 2923 2927 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 3147 3150 <span type="species:ncbi:11673?1.0">FIV</span>
All APOBEC3s are expressed as carboxy-terminal HA-tagged proteins (APOBEC3-HA). Feline APOBEC3Ca (previously termed feAPOBEC3, feA3, GenBank accession no. ) was described in [21]. Feline APOBEC3Cb and APOBEC3Cc were similarly constructed. Feline APOBEC3H and feline APOBEC3CH cDNAs were identified by using 5' and 3' RACE reactions (5'/3'-RACE kit, Roche Diagnostics) employing total RNA from CrFK cells [24]. APOBEC3 cDNAs of big cats were amplified from cDNA of PBMCs after activation with PHA (3 mug/ml) and Pwo polymerase (Roche Diagnostics) was applied. The primers were: for A3C forward primer fApo3F-18 (5'-TAGAAGCTTACCAAGGCTGGCGAGAGGAATGG-3', HindIII site underlined) and reverse primer fAPO3F-19 (5'-AGCTCGAGTCAAGCGTAATCTGGAACATCGTATGGATACCTAAGGATTTCTTGAAGCTCTGC-3' (XhoI site underlined)); for A3H, forward primer fAPO-29 (5'-TGCATCGGTACCTGGAGGCAGCCTGGGAGGTG-3' (KpnI site underlined)) and reverse primer fAPO-28 (5'-AGCTCGAGTCAAGCGTAATCTGGAACATCGTATGGATATTCAAGTTTCAAATTTCTGAAG-3' (XhoI site underlined)). Thirty cycles were run at 94degreesC for 30 s, 58degreesC for 1 minute, and 72degreesC for 2 minutes. PCR products were cloned into pcDNA3.1(+) using restriction sites HindIII and XhoI (for A3C) or KpnI and XhoI (for A3H) and sequenced. Expression plasmids of 3'-HA-tagged dog (C. familiaris) APOBEC3A (GenBank accession number. ) and APOBEC3H (GenBank accession number ) were generated by PCR. For dog A3A the template was expressed sequence tag clone nas31ho7 5' (GenBank accession number ), obtained through Graeme Wistow from the National Eye Institute, Bethesda, USA, and Pwo polymerase was used. The forward primer was dog-APO-11 (5'-TGCAGGTACCCCGCGGACATGGAGGCTGGCC-3' (KpnI site underlined)), and the reverse primer was Dog-APO-10 (5' AGTGCGGCCGCTCAAGCGTAATCTGGAACATCGTATGGATATAGGCAGACTGAGGTCCATCC-3' (NotI site underlined)). Dog A3H cDNA was amplified from cDNA of PBMCs after activation with PHA (3 mug/ml), using forward primer Dog-APO-7 (5'-TGCAGGTACCCCACGATGAATCCACTACAAGAAGA-3' (KpnI site underlined)), and reverse primer Dog-APO-8 (5'-AGTGCGGCCGCTCAAGCGTAATCTGGAACATCGTATGGATAAAGTCTCAAATTTCTGAAGTC-3' (NotI site underlined)), and Pwo polymerase (Roche). Thirty cycles were run at 94degreesC for 30 s, 58degreesC for 1 minute, and 72degreesC for 2 minutes. PCR products were digested by KpnI and NotI, introduced into pcDNA3.1(+)-Zeo (Invitrogen) and correct clones identified by sequencing. For generation of the pGex-feAPOBEC3CH-linker the feline A3CH linker region containing the sequence from amino acids 190-244 of the feline A3CH was cloned into a pGEX-4T3 Vector (Amersham Bioscience, Freiburg, Germany) by PCR (forward primer, 5'-CGAGTCGAATTCCCTTAGTCCCGGCCAACAAAGAAAAAGAGAC-3'; reverse primer, 5'-GCATGAGTCGACTGTGGGTCTGGGCAAGAGGAAGG-3'; the introduced restriction sites for EcoRI and SalI are underlined). Purified DNA fragments were fused in frame between the 5' GST domain and the 3' SV40 tag (KPPTPPPEPET) of correspondingly digested pGEX4T3tag derivatives [84]. Clones were identified by restriction enzyme digestion and DNA sequencing. pcFIV.Vif-V5 is an expression plasmid for the codon-optimized vif of FIV-34TF10 (GenBank accession number ). It was generated by cloning the codon-optimized vif gene, 3' fused to the V5-tag, made by Geneart (Regensburg, Germany) into pcDNA3.1(+) using the KpnI and NotI restriction sites; a 3'-WPRE element was included in the NotI and ApaI sites.
###end p 68
###begin title 69
Expression studies
###end title 69
###begin p 70
###xml 777 781 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pwo </italic>
###xml 825 829 824 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
###xml 108 111 <span type="species:ncbi:9685">cat</span>
Expression studies of feline APOBEC3C RNAs in CrFK, KE-R, MYA-1, and Fet1C cells and PHA-activated PMBCs of cat and other Felidae were done by RT-PCR using 2 mug of total RNA (RNeasy mini kit, Qiagen) and cDNA made by SuperScript III RT (Invitrogen). For feline APOBEC3Cs the primers were forward fAPO3F-9 (5'-TGGAGGCAGCCTGGGAGGTG-3'), and reverse fAPO3F-15 (5'-GCGAGACGCAAGGAACAGCAG-3'). For feline APOBEC3H the primers were forward fAPO3F-9 and reverse fAPO-26 (5'-CTGCCCGAAGGCACCCTAATTC-3'), or, alternatively, forward feA3H.fw (5'-ATGAATCCACTACAGGAAGTCATAT-3') and reverse feA3H.rv (5-TCATTCAAGTTTCAAATTTCTGAAG-3'). For feline APOBEC3CH the primers were forward feAPO3CH.fw (5'-ATGGAGCCCTGGCGCCCCAGCCCAA-3') and reverse fAPO-27 (5'-TCGTACTCGAGGCAGTTTATGAAGCATTGAGATGC-3'). Pwo polymerase (Roche) was used for cloning and Taq polymerase (Fermentas, St. Leon-Rot, Germany) for diagnostic PCR. PCRs were run for 30 cycles at 94degreesC for 30 s, annealing for 1 minute at 60degreesC for feA3C, 58degreesC for feA3H, and 59degreesC for feA3CH, and 72degreesC for 2 minutes. PCR products were cloned in TOPO-vectors (Invitrogen) and sequenced.
###end p 70
###begin title 71
Immunoblot analysis
###end title 71
###begin p 72
###xml 1297 1299 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 43 46 <span type="species:ncbi:53182">FFV</span>
###xml 48 51 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 53 57 <span type="species:ncbi:11768">FeLV</span>
###xml 630 635 <span type="species:ncbi:10090">mouse</span>
###xml 717 723 <span type="species:ncbi:9986">rabbit</span>
###xml 803 814 <span type="species:ncbi:3704">horseradish</span>
###xml 837 843 <span type="species:ncbi:9986">rabbit</span>
###xml 849 854 <span type="species:ncbi:10090">mouse</span>
###xml 871 876 <span type="species:ncbi:10090">mouse</span>
###xml 1041 1047 <span type="species:ncbi:9986">rabbit</span>
###xml 1288 1295 <span type="species:ncbi:9986">rabbits</span>
Cells were cotransfected with plasmids for FFV, FIV, FeLV and APOBEC3-HA expression plasmids and lysates were prepared two days later. Cell lysates were prepared by removing the medium from transfected cells, washing them with phosphate-buffered saline, and lysing them in lysis buffer. Protein in the lysates was quantified using Coomassie blue reagent (Bio-Rad, Munich, Germany). Lysates containing 20 mug of protein were separated by SDS-PAGE and transferred to polyvinylidene difluoride filters or nitrocellulose membranes. Filters were probed with anti-HA antibody (1:6,000 dilution, MMS-101P; Covance, Munster, Germany), or mouse anti-alpha-tubulin (1:4,000 dilution, clone B5-1-2, Sigma-Aldrich) or polyclonal rabbit antibody against the linker region of feline A3CH (1:250 dilution) followed by horseradish peroxidase-conjugated rabbit anti-mouse antibody (alpha-mouse-IgG-HRP, Amersham Biosciences) or Protein A-peroxidase (Sigma) and developed with ECL chemiluminescence reagents (Amersham Biosciences). A polyclonal mono-specific rabbit antiserum against the feline A3CH linker sequence (A3CH amino acid residues 190-244) was generated using a GST-fusion protein made with a pGex-feAPOBEC3CH-linker. The GST-fusion protein was purified as described and used for vaccination of rabbits [21].
###end p 72
###begin title 73
Data deposition
###end title 73
###begin p 74
###xml 583 587 579 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 294 297 <span type="species:ncbi:9685">cat</span>
###xml 331 338 <span type="species:ncbi:9691">leopard</span>
###xml 347 352 <span type="species:ncbi:9694">tiger</span>
###xml 363 368 <span type="species:ncbi:9694">tiger</span>
###xml 379 384 <span type="species:ncbi:9694">tiger</span>
###xml 395 399 <span type="species:ncbi:9689">lion</span>
###xml 410 414 <span type="species:ncbi:9689">lion</span>
###xml 485 489 <span type="species:ncbi:9696">puma</span>
###xml 498 505 <span type="species:ncbi:9691">leopard</span>
###xml 514 519 <span type="species:ncbi:9694">tiger</span>
###xml 528 532 <span type="species:ncbi:9689">lion</span>
###xml 554 558 <span type="species:ncbi:9696">puma</span>
###xml 590 593 <span type="species:ncbi:11673?1.0">FIV</span>
The sequences reported here have been deposited in the GenBank database: feline A3 genomic locus, including feA3Ca, feA3Cb, feA3Cc, and feA3H (); feA3Ca (); feA3C isolate X (); feA3C isolate Y (); feA3H (); feA3H (Ex2 5'Delta) (); feA3CH (); feA1, feA2, feA4, and AICDA (sequences derived from cat genomic project AANG00000000.1); leopard A3C (); tiger A3C#1 (); tiger A3C#2 (); tiger A3C#3 (); lion A3C#1 (); lion A3C#2 (); lynx A3C#1 (); lynx A3C#2 (); lynx A3C#5 (); lynx A3C#6 (); puma A3C (); leopard A3H (); tiger A3H (); lion A3H (); lynx A3H (); puma A3H (); codon optimized vif of FIV ().
###end p 74
###begin title 75
Abbreviations
###end title 75
###begin p 76
###xml 153 159 <span type="species:ncbi:9913">bovine</span>
###xml 167 171 <span type="species:ncbi:11768">FeLV</span>
###xml 173 194 <span type="species:ncbi:11768">feline leukemia virus</span>
###xml 196 199 <span type="species:ncbi:53182">FFV</span>
###xml 201 219 <span type="species:ncbi:53182">feline foamy virus</span>
###xml 221 224 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 226 255 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
###xml 276 279 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 281 309 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 575 578 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 580 609 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 686 712 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
A3, APOBEC3; AICDA, activation-induced cytidine deaminase (also known as AID; APOBEC3, apolipoprotein B mRNA-editing catalytic polypeptide 3; FBS, fetal bovine serum; FeLV, feline leukemia virus; FFV, feline foamy virus; FIV, feline immunodeficiency virus; HA, hemagglutinin; HIV, human immunodeficiency virus; Luc, luciferase; NCBI, National Center for Biotechnology Information; PAML, Phylogenetic Analysis by Maximum Likelihood; PBMCs, peripheral blood mononuclear cells; PHA, phytohemagglutinin; RACE, rapid amplification of cDNA ends; RT-PCR, reverse-transcriptase PCR; SIV, simian immunodeficiency virus; SNP, single nucleotide polymorphism; Vif, viral infectivity factor; VSV-G, vesicular stomatitis virus-G protein; WGS, whole genome shotgun.
###end p 76
###begin title 77
Authors' contributions
###end title 77
###begin p 78
CM, ML and NY designed the study, analyzed data and wrote the manuscript. TB characterized the genomic A3 locus, characterized the SNPs and wrote the manuscript. AHW and IGB performed bioinformatics and wrote the manuscript. JZ, SC and MB performed cell culture and biochemical experiments. KC and SOB contributed material/reagents/analysis tools and analyzed data. JT characterized and provided reagents.
###end p 78
###begin title 79
Additional data files
###end title 79
###begin p 80
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 563 564 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 794 795 794 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 899 900 899 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 995 996 995 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 234 237 <span type="species:ncbi:9685">cat</span>
###xml 291 294 <span type="species:ncbi:9685">cat</span>
###xml 343 346 <span type="species:ncbi:9685">cat</span>
###xml 749 754 <span type="species:ncbi:9606">human</span>
###xml 1042 1045 <span type="species:ncbi:11673?1.0">FIV</span>
The following additional data are available with the online version of this paper. Additional data file 1 provides supplemental information about the calculation of Ka/Ks. Additional file 2 provides tables showing percent identity of cat A3C introns (supplementary Table 1), Ka/Ks ratios of cat A3s (supplementary Tables 2 and 3), A3C SNPs of cat breeds (supplementary Table 4), percent identities of all described A3C and A3H cDNAs and proteins (supplementary Tables 5 and 6) and results of different evolutionary models (supplementary Table 7). Additional file 3 provides supplementary figures. Supplementary Figure 1 shows amino acid alignments of feline APOBEC3 proteins. Supplementary Figure 2 shows amino acid alignments of feline, canine and human APOBEC3 proteins. Supplementary Figure 3 contains sequences and positions of predicted transcription factor binding sites. Supplementary Figure 4 shows analysis of evolutionary selection by the sliding window approach. Supplementary Figure 5 presents analysis of cytidine deamination of FIV by feline A3s.
###end p 80
###begin title 81
Supplementary Material
###end title 81
###begin title 82
Additional data file 1
###end title 82
###begin p 83
Information about the calculation of Ka/Ks.
###end p 83
###begin p 84
Click here for file
###end p 84
###begin title 85
Additional data file 2
###end title 85
###begin p 86
###xml 48 51 <span type="species:ncbi:9685">cat</span>
###xml 115 118 <span type="species:ncbi:9685">cat</span>
###xml 164 167 <span type="species:ncbi:9685">cat</span>
Supplementary Table 1 lists percent identity of cat A3C introns. Supplementary Tables 2 and 3 list Ka/Ks ratios of cat A3s. Supplementary Table 4 lists A3C SNPs of cat breeds. Supplementary Tables 5 and 6 list percent identities of all described A3C and A3H cDNAs and proteins. Supplementary Table 7 lists results of different evolutionary models.
###end p 86
###begin p 87
Click here for file
###end p 87
###begin title 88
Additional data file 3
###end title 88
###begin p 89
###xml 417 421 417 421 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 533 537 533 537 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 615 619 615 619 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 1379 1383 1379 1383 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 1405 1409 1405 1409 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 1718 1722 1718 1722 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 1755 1759 1755 1759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">egfp</italic>
###xml 1808 1812 1804 1808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 2134 2138 2130 2134 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 2187 2191 2181 2185 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 2293 2297 2281 2285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 2342 2346 2330 2334 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 2379 2383 2363 2367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif </italic>
###xml 239 242 <span type="species:ncbi:9685">cat</span>
###xml 393 398 <span type="species:ncbi:9606">human</span>
###xml 485 490 <span type="species:ncbi:9606">human</span>
###xml 514 520 <span type="species:ncbi:10090">murine</span>
###xml 577 582 <span type="species:ncbi:9606">human</span>
###xml 596 602 <span type="species:ncbi:10090">murine</span>
###xml 643 648 <span type="species:ncbi:9606">human</span>
###xml 670 675 <span type="species:ncbi:9606">human</span>
###xml 918 930 <span type="species:ncbi:9685">domestic cat</span>
###xml 1383 1386 <span type="species:ncbi:9685">cat</span>
###xml 1409 1412 <span type="species:ncbi:9685">cat</span>
###xml 1478 1483 <span type="species:ncbi:9606">human</span>
###xml 1694 1697 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1812 1815 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1842 1845 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 2297 2300 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 2383 2386 <span type="species:ncbi:11673?1.0">FIV</span>
Figure S1: comparison of amino acid sequences of the feline A3C genes. Predicted amino acid sequence of the feline APOBEC3Ca, APOBEC3Cb and APOBEC3Cc proteins in comparison with the two additional variant cDNAs detected (A3Cx and A3Cy) in cat PBMCs. The zinc coordination domain is indicated. Residues different to A3Ca are shown in bold. Figure S2: amino acid alignment of feline, canine and human APOBEC3 proteins. (a) Amino acid alignment of feline APOBEC3Ca, APOBEC3Cb, APOBEC3Cc, human APOBEC3C, APOBEC3F and murine APOBEC3 NT. (b) Amino acid alignment of feline, canine, human APOBEC3H and murine APOBEC3 NT. (c) Amino acid alignment of human, canine APOBEC3A and human APOBEC3G CT. The zinc-coordinating domains are indicated. CT, carboxyl-terminal domain; NT, amino-terminal domain. Figure S3: prediction of transcription factor binding sites. Potential transcription factor binding sites in A3 cluster of the domestic cat in the region 1.1 kb upstream, including 100 bp of the predicted exon 1 for each gene (A3Ca, A3Cb, A3Cc and A3H) using ClustalW. The individual 5' flanking sequences were analyzed using the program Match, which uses a library of nucleotide weight matrices from the TRANSFAC6.0 database for transcription factor binding sites. Figure S4: analysis of Ka/Ks. Sliding window (300 bp window, 50 bp slide) analysis of Ka and Ks was performed on pairs of (a) cat A3C sequences and (b) cat A3H sequences and compared with corresponding selected felid and human sequences. Ka/Ks is plotted against the length of the coding region of the mRNAs with a schematic presentation of protein domains along the x-axis. Figure S5: analysis of cytidine deamination in the genomes of FIV by feline APOBEC3s. (a) A fragment of the reporter gene (egfp) was amplified from reverse transcripts of Deltavif FIV (left panel) or wild-type FIV (right panel) generated in the presence of the indicated feline APOBEC3s 10 h post-infection. A total of eight independent nucleotide sequences were determined. The mutations in the clones of each group are shown. Each mutation is indicated and coded with respect to nucleotide mutation. (b) The number of G-->A changes per 100 Gs is shown. (c) Comparison of the dinucleotide sequence context of G-->A mutations in the positive-strand DNA of Deltavif FIV derived from feA3-expressing 293T cells. (d) Sequence characteristics of Deltavif FIV DNA genomes of virions derived from 293T-expressing feline APOBEC3 proteins or empty expression plasmid (vector).
###end p 89
###begin p 90
Click here for file
###end p 90
###begin title 91
Acknowledgements
###end title 91
###begin p 92
###xml 334 338 <span type="species:ncbi:11768">FeLV</span>
###xml 833 838 <span type="species:ncbi:9606">Human</span>
We thank Bjorn-Philpp Kloke, Henning Hofmann, Lisa Maslan, Kathy Kelley, and Xiaoxin Li for expert technical assistance and Victor David, Christiane Kiefert, Karin Kliemann, Nathaniel R Landau, Garry P Nolan, Roland Plesker, Eric M Poeschla, Marylyn Raymond, Roland Riebe, and Graeme Wistow for the gift of reagents. The reagent p61E-FeLV from James Mullins was obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH. IG Bravo is supported by the Initiative on Evolutionary Biology from the Volkswagen Foundation. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.
###end p 92
###begin article-title 93
The Feline Genome Project.
###end article-title 93
###begin article-title 94
###xml 39 42 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 46 50 <span type="species:ncbi:9685">cats</span>
###xml 66 69 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Transmission and immunopathogenesis of FIV in cats as a model for HIV.
###end article-title 94
###begin article-title 95
###xml 14 35 <span type="species:ncbi:11768">feline leukemia virus</span>
###xml 40 69 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
Infections of feline leukemia virus and feline immunodeficiency virus.
###end article-title 95
###begin article-title 96
###xml 73 77 <span type="species:ncbi:9685">cats</span>
###xml 107 125 <span type="species:ncbi:53182">feline foamy virus</span>
Characterization of the humoral immune response and virus replication in cats experimentally infected with feline foamy virus.
###end article-title 96
###begin article-title 97
###xml 86 97 <span type="species:ncbi:11963">foamy virus</span>
Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors.
###end article-title 97
###begin article-title 98
###xml 64 93 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus among Felidae and Hyaenidae species.
###end article-title 98
###begin article-title 99
###xml 51 54 <span type="species:ncbi:9685">cat</span>
Initial sequencing and comparative analysis of the cat genome.
###end article-title 99
###begin article-title 100
Intrinsic immunity: a front-line defense against viral attack.
###end article-title 100
###begin article-title 101
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.
###end article-title 101
###begin article-title 102
Retroviral restriction by APOBEC proteins.
###end article-title 102
###begin article-title 103
APOBEC-mediated viral restriction: not simply editing?
###end article-title 103
###begin article-title 104
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
###end article-title 104
###begin article-title 105
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 50 85 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.
###end article-title 105
###begin article-title 106
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 69 74 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 79 84 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.
###end article-title 106
###begin article-title 107
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.
###end article-title 107
###begin article-title 108
Cytidine deamination of retroviral DNA by diverse APOBEC proteins.
###end article-title 108
###begin article-title 109
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.
###end article-title 109
###begin article-title 110
###xml 47 76 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.
###end article-title 110
###begin article-title 111
###xml 26 43 <span type="species:ncbi:10407">hepatitis B virus</span>
Comment on "Inhibition of hepatitis B virus replication by APOBEC3G".
###end article-title 111
###begin article-title 112
Feline lentivirus evolution in cross-species infection reveals extensive G-to-A mutation and selection on key residues in the viral polymerase.
###end article-title 112
###begin article-title 113
###xml 59 70 <span type="species:ncbi:11963">foamy virus</span>
The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein.
###end article-title 113
###begin article-title 114
###xml 14 48 <span type="species:ncbi:11908">human T cell leukemia virus type 1</span>
Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid.
###end article-title 114
###begin article-title 115
###xml 0 11 <span type="species:ncbi:11963">Foamy virus</span>
Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors.
###end article-title 115
###begin article-title 116
###xml 25 60 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Multiple restrictions of human immunodeficiency virus type 1 in feline cells.
###end article-title 116
###begin article-title 117
Spidey: a tool for mRNA-to-genomic alignments.
###end article-title 117
###begin article-title 118
GeneWise and Genomewise.
###end article-title 118
###begin article-title 119
Fitting a mixture model by expectation maximization to discover motifs in biopolymeres.
###end article-title 119
###begin article-title 120
Methods and statistics for combining motif match scores.
###end article-title 120
###begin article-title 121
Database TRANSFAC
###end article-title 121
###begin article-title 122
An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.
###end article-title 122
###begin article-title 123
###xml 48 53 <span type="species:ncbi:9606">human</span>
Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene.
###end article-title 123
###begin article-title 124
Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.
###end article-title 124
###begin article-title 125
Rapid evolution of primate antiviral enzyme APOBEC3G.
###end article-title 125
###begin article-title 126
The late Miocene radiation of modern Felidae: a genetic assessment.
###end article-title 126
###begin article-title 127
PAML
###end article-title 127
###begin article-title 128
PAML: a program package for phylogenetic analysis by maximum likelihood.
###end article-title 128
###begin article-title 129
The Selecton Server
###end article-title 129
###begin article-title 130
Selecton 2007: advanced models for detecting positive and purifying selection using a Bayesian inference approach.
###end article-title 130
###begin article-title 131
###xml 16 34 <span type="species:ncbi:53182">feline foamy virus</span>
The bet gene of feline foamy virus is required for virus replication.
###end article-title 131
###begin article-title 132
Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
###end article-title 132
###begin article-title 133
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
###end article-title 133
###begin article-title 134
A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).
###end article-title 134
###begin article-title 135
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 95 100 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
###end article-title 135
###begin article-title 136
###xml 104 107 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.
###end article-title 136
###begin article-title 137
APOBEC3G genetic variants and their influence on the progression to AIDS.
###end article-title 137
###begin article-title 138
Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.
###end article-title 138
###begin article-title 139
###xml 20 38 <span type="species:ncbi:53182">feline foamy virus</span>
Genetic analyses of feline foamy virus isolates from domestic and wild feline species in geographically distinct areas.
###end article-title 139
###begin article-title 140
###xml 28 57 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
Analysis of the vif gene of feline immunodeficiency virus.
###end article-title 140
###begin article-title 141
The evolution of functionally novel proteins after gene duplication.
###end article-title 141
###begin article-title 142
The probability of duplicate gene preservation by subfunctionalization.
###end article-title 142
###begin article-title 143
###xml 42 47 <span type="species:ncbi:9606">human</span>
Transcription-mediated gene fusion in the human genome.
###end article-title 143
###begin article-title 144
###xml 66 71 <span type="species:ncbi:9606">human</span>
Tandem chimerism as a means to increase protein complexity in the human genome.
###end article-title 144
###begin article-title 145
APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition.
###end article-title 145
###begin article-title 146
Delay in synthesis of the 3' splice site promotes trans-splicing of the preceding 5' splice site.
###end article-title 146
###begin article-title 147
###xml 69 72 <span type="species:ncbi:10116">rat</span>
Natural trans-splicing in carnitine octanoyltransferase pre-mRNAs in rat liver.
###end article-title 147
###begin article-title 148
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 31 37 <span type="species:ncbi:10090">murine</span>
Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms.
###end article-title 148
###begin article-title 149
Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins.
###end article-title 149
###begin article-title 150
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 42 48 <span type="species:ncbi:10090">murine</span>
Comparative genome organization of human, murine, and feline MHC class II region.
###end article-title 150
###begin article-title 151
Base-calling of automated sequencer traces using phred. II. Error probabilities.
###end article-title 151
###begin article-title 152
Base-calling of automated sequencer traces using phred. I. Accuracy assessment.
###end article-title 152
###begin article-title 153
Consed: a graphical tool for sequence finishing.
###end article-title 153
###begin article-title 154
RepeatMasker
###end article-title 154
###begin article-title 155
###xml 42 47 <span type="species:ncbi:9606">human</span>
Prediction of complete gene structures in human genomic DNA.
###end article-title 155
###begin article-title 156
Spidey
###end article-title 156
###begin article-title 157
PipMaker - a web server for aligning two genomic DNA sequences.
###end article-title 157
###begin article-title 158
Match
###end article-title 158
###begin article-title 159
WebLogo
###end article-title 159
###begin article-title 160
WebLogo: a sequence logo generator.
###end article-title 160
###begin article-title 161
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
###end article-title 161
###begin article-title 162
The Jalview Java alignment editor.
###end article-title 162
###begin article-title 163
PHYLIP
###end article-title 163
###begin article-title 164
MUSCLE: multiple sequence alignment with high accuracy and high throughput.
###end article-title 164
###begin article-title 165
Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis.
###end article-title 165
###begin article-title 166
BEAST
###end article-title 166
###begin article-title 167
RAxML
###end article-title 167
###begin article-title 168
RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic trees.
###end article-title 168
###begin article-title 169
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene.
###end article-title 169
###begin article-title 170
###xml 89 94 <span type="species:ncbi:9606">human</span>
Maximum likelihood estimation on large phylogenies and analysis of adaptive evolution in human influenza virus A.
###end article-title 170
###begin article-title 171
###xml 0 3 <span type="species:ncbi:11673?1.0">FIV</span>
FIV Vectors.
###end article-title 171
###begin article-title 172
###xml 57 86 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors.
###end article-title 172
###begin article-title 173
###xml 24 45 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 68 94 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus.
###end article-title 173
###begin article-title 174
Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.
###end article-title 174
###begin article-title 175
###xml 31 36 <span type="species:ncbi:9606">human</span>
Stable transduction of primary human monocytes by simian lentiviral vector PBj.
###end article-title 175
###begin article-title 176
HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase.
###end article-title 176
###begin article-title 177
The delayed rise of present-day mammals.
###end article-title 177
###begin article-title 178
Evolutionary biology: re-crowning mammals.
###end article-title 178
###begin article-title 179
Cretaceous eutherians and Laurasian origin for placental mammals near the K/T boundary.
###end article-title 179

